Nextdoor and Freshpaint Partner to Give Healthcare Advertisers Compliant, Measurable Local Performance

Nextdoor and Freshpaint Partner to Give Healthcare Advertisers Compliant, Measurable Local Performance

Healthcare advertisers can now measure what hyperlocal advertising actually drives, reaching verified neighbors and household decision-makers without the compliance risk

SAN FRANCISCO–(BUSINESS WIRE)–
Nextdoor, the essential neighborhood network, and Freshpaint, the privacy-safe customer data platform built for healthcare, today announced a new integration that enables healthcare advertisers to measure the impact of hyperlocal advertising on real patient outcomes – without compromising privacy or compliance. The integration connects Nextdoor’s Ads Manager to Freshpaint’s privacy-first platform, allowing healthcare marketing teams to form a direct, controlled link between neighborhood-level campaign performance and downstream patient actions like booked appointments, attended visits, and new patient volume.

With the Nextdoor-Freshpaint integration, healthcare marketers can unlock access to metrics that go beyond clicks and form fills, connecting their hyperlocal campaigns to bottom-funnel conversions so they can confidently double down on hyperlocal advertising as a measurable, scalable driver of patient acquisition.

The integration delivers:

  • Incremental local reach among verified household decision-makers not duplicated by search or other social platforms
  • Neighborhood-level attribution tied to specific service lines, zip codes, and campaigns – not just clicks and impressions
  • PHI protection by default through server-side data collection with full governance and auditability
  • A single view of local growth from first neighborhood exposure to patient acquisition

“Healthcare marketers shouldn’t have to trade off between performance and privacy,” said Jason Powers, Vice President of Product at Freshpaint. “By turning hyperlocal advertising into a true performance channel with Nextdoor, we’re empowering healthcare organizations to see exactly which neighborhoods and campaigns lead to patient actions – so they can measure what’s working and improve performance, without compromising privacy.”

“Healthcare is deeply personal, and the decisions patients make start close to home – with neighbors, local recommendations, and trusted community conversations,” said Michael Kiernan, Chief Revenue Officer at Nextdoor. “Nextdoor is the only platform that reaches 110 million verified neighbors at their real addresses, which means healthcare advertisers aren’t just buying impressions, they’re reaching actual household decision-makers in the specific neighborhoods they serve.”

The Freshpaint-Nextdoor integration is available now. Healthcare advertisers interested in getting started can visit business.nextdoor.com to learn more.

About Nextdoor

Nextdoor is the essential neighborhood network for over 110 million verified neighbors, offering trusted local news, real-time safety alerts, neighbor recommendations, for sale and free listings, and local events. Nextdoor connects neighbors to the people, places, and information that matter most in their local communities. In addition, businesses, news publishers, and public agencies use Nextdoor to share important information and engage with neighbors at scale. Download the app or join the neighborhood at nextdoor.com. For more information and media assets, visit nextdoor.com/newsroom.

About Freshpaint

Freshpaint is built for healthcare marketers to deliver measurable performance while safeguarding patient trust in a complex regulatory environment. Bringing privacy and performance together in one platform, Freshpaint enables healthcare organizations to securely connect and activate data across channels, connect marketing spend to outcomes, and confidently scale growth. Headquartered in San Francisco, Freshpaint partners with more than 250 healthcare organizations – including enterprise providers, payers, digital health companies, agencies, and consumer health brands – so that marketers are empowered to stretch fixed budgets, prove what’s working, and turn privacy into a strategic advantage that fuels performance.

To learn more, visit freshpaint.io and follow Freshpaint on LinkedIn.

Media Relations:

Kelsey Grady

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Technology Construction & Property Marketing Advertising Communications Health Technology Software Practice Management Health Residential Building & Real Estate

MEDIA:

Logo
Logo

NGL Energy Partners Announces Earnings Call

NGL Energy Partners Announces Earnings Call

TULSA, Okla.–(BUSINESS WIRE)–
NGL Energy Partners LP (NYSE: NGL) announced today that it plans to issue its year ended March 31, 2026, earnings press release, post-market close on Thursday, May 28, 2026. Members of NGL’s management team intend to host an earnings call following this release on Thursday, May 28, 2026, at 4:00 pm CDT to discuss its financial results. Analysts, investors, and other interested parties may join the webcast via the event link: https://www.webcaster5.com/Webcast/Page/2808/54031 or by dialing (888) 506-0062 and providing conference code: 941890. An archived audio replay of the call will be available for 14 days, which can be accessed by dialing (877) 481-4010 and providing replay passcode 54031.

About NGL Energy Partners LP

NGL Energy Partners LP, a Delaware limited partnership, operates the largest integrated network of large diameter wastewater pipelines, disposal wells and produced water handling systems in the Delaware Basin. NGL also operates wastewater disposal in the Eagle Ford and DJ Basins. In addition, NGL markets and provides other logistics services for crude oil, through its ownership of the Grand Mesa Pipeline System, Cushing terminal and other Gulf Coast terminals. For further information, visit the Partnership’s website at www.nglenergypartners.com.

This release is a qualified notice under Treasury Regulation Section 1.1446-4(b). Brokers and nominees should treat 100% of NGL Energy Partners LP’s distributions to foreign investors as being attributable to income that is effectively connected with a United States trade or business. Therefore, distributions to foreign investors are subject to federal income tax withholding at the highest applicable effective tax rate.

NGL Energy Partners LP

David Sullivan, 918.495.4631

Vice President – Finance

[email protected]

KEYWORDS: Oklahoma United States North America

INDUSTRY KEYWORDS: Energy Other Energy Oil/Gas

MEDIA:

Logo
Logo

Bimergen Energy to Present May 18th a $2B Asset Growth Plan at the LD Micro 16th Annual Invitational

Newport Beach, CA, May 12, 2026 (GLOBE NEWSWIRE) — Bimergen Energy Corporation (NYSE American: BESS, BESS.WS), a developer, owner, and operator of utility-scale and distributed battery energy storage systems (BESS) across the United States, today announced that the Company will participate in the LD Micro 16th Annual Invitational, taking place May 17-19 , 2026, at the Luxe Sunset Boulevard Hotel in Los Angeles, California.

Bimergen’s Co-CEO, Bob Brilon, will deliver a corporate presentation on Monday, May 18th at 3:30 pm Pacific Time, as well as conduct one-on-one meetings with investors during the conference.

The LD Micro Invitational is one of the premier investor conferences focused on microcap companies, bringing together leading institutional investors and emerging growth companies for presentations and networking opportunities.

Bimergen plans to discuss status of the projects moving towards being operational in Texas in the near term, $2 billion growth strategy from its development pipeline of battery energy storage projects totaling approximately 2.0 GW of estimated capacity across key U.S. power markets, including ERCOT, PJM, WECC, CAISO and MISO. Bimergen will also discuss the simple energy arbitrage revenue model that capitalizes on the increasing demand and increasing prices for electricity while making more power available to the grid when it is needed. Bimergen’s strategy is battery technology agnostic, which makes them unique, and focused on owning and operating these revenue producing battery storage farms. Bimergen’s strategy includes the use of strategic and long-term debt and long-term offtake agreements that support stable, contract-backed revenue streams. The debt will be at the project level with no recourse to Bimergen and no Bimergen equity dilution.

About Bimergen Energy Corporation

Bimergen Energy Corporation (NYSE American: BESS, BESSWS) is a U.S.-based independent power producer specializing in the development, ownership, and operation of standalone battery energy storage systems (BESS). Bimergen develops utility-scale and distributed storage projects designed to provide grid reliability, renewable integration, and flexible energy solutions. Bimergen manages the full project lifecycle, including site selection, permitting, engineering, procurement, construction, and operations. Its portfolio spans multiple power markets across the United States.

For more information about Bimergen Energy, please visit www.bimergen.com.

Forward Looking Statements

This press release contains “forward-looking statements” that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” “will” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Bimergen Energy Corporation’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully in the section titled “Risk Factors” in the final prospectus related to the public offering filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date, and Bimergen Energy Corporation undertakes no duty to update such information except as required under applicable law.

Contact:

Dave Gentry
RedChip Companies Inc.
1-407-644-4256 | 1-800-REDCHIP (733-2447)
[email protected]



ProMIS Neurosciences Announces First Quarter 2026 Financial Results and Provides Corporate Highlights


  • Company closed PIPE financing with gross proceeds of up to $175 million, including the possible exercise of warrants, from long-term global investors. Proceeds are expected to fund the Company through 2027, including completion of the ongoing Phase 1b clinical trial in Alzheimer’s disease (AD).

  • PRECISE-AD Phase 1b trial is fully enrolled and progressing on schedule, with the blinded 6-month interim analysis anticipated in early Q3 2026 and 12-month top-line data anticipated in early 2027. 

  • The planned interim analysis is expected to include a qualitative assessment of aggregated safety data, including amyloid-related imaging abnormalities (ARIA) incidence, as well as key biomarker trends across all study participants at the 6-month timepoint.

Cambridge, Massachusetts, May 12, 2026 (GLOBE NEWSWIRE) — ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases, today announced its financial results for the quarter ended March 31, 2026, and provided a corporate update.

“2026 has the potential to be a significant year for patients with Alzheimer’s disease and their caregivers,” said Neil Warma, Chief Executive Officer of ProMIS Neurosciences.  “We believe ProMIS is well-positioned with PMN310 as a potentially differentiated treatment for patients with early AD.  We are coming off a productive quarter, having closed a transformational financing of up to $175 million, including potential proceeds from warrant exercises, and have executed well on our Phase 1b clinical trial. Near-term data catalysts, including the blinded 6-month interim analysis, are anticipated in early Q3 2026, and could provide important insight into the potential of our lead drug candidate, PMN310.

With currently marketed AD therapies, safety remains a central concern. Both approved plaque-directed antibodies carry black box warnings for a serious side effect known as ARIA, which encompasses cerebral edema (ARIA-E) and microhemorrhages (ARIA-H) in the brain. ARIA is believed to be associated with therapies that bind amyloid plaque. Given the modest clinical benefit observed with these therapies, ARIA-related risk has been a meaningful consideration in real-world treatment decisions for many patients and physicians.

A growing body of evidence supports the view that toxic soluble amyloid-beta oligomers, small soluble species that form upstream of plaque, are a primary driver of cognitive decline in AD. PMN310 has been designed to selectively target these toxic oligomers while sparing plaque, a mechanism we believe may enable improved efficacy and a differentiated safety profile relative to plaque-directed antibodies.

ProMIS’s Phase 1b trial, PRECISE-AD, was fully enrolled in December 2025, exceeding the company’s target, and we are now approaching the 6-month timepoint of the trial. The upcoming blinded interim data analysis anticipated in early Q3 2026 will summarize aggregate safety data and overall trends in key biomarkers across all study participants, without revealing treatment assignments. Because the analysis pools active and placebo groups under the blind, even modest directional changes could provide early indications of target engagement while preserving the integrity of the trial.

ProMIS expects to complete 12-month dosing for all patients by year-end and to report unblinded top-line results in early 2027, providing a comprehensive view of PMN310’s safety, biomarker, and clinical outcomes by treatment group, and an important clinical test of PMN310’s selective targeting approach.”

Corporate Highlights

Alzheimer’s Disease (AD) Program (PMN310)

  • The Company is conducting the PRECISE‑AD Phase 1b clinical trial, which is fully enrolled with 144 participants across three dosing cohorts receiving treatment over a 12‑month period.
  • A blinded interim analysis is anticipated in early third quarter 2026, providing a mid‑study review of aggregated safety data and overall biomarker trends across all participants. As this analysis remains blinded, individual treatment assignments will not be disclosed, and results will represent combined data from both active and placebo groups. While this interim analysis is not designed to assess clinical efficacy, this early look may reveal directional biomarker trends that offer early insight into target engagement.
  • Full patient dosing is expected to be completed by year‑end 2026, with unblinded top‑line results anticipated in early 2027. At that time, the Company expects to evaluate biomarker outcomes and clinical measures by treatment group, providing a comprehensive understanding of PMN310’s potential in Alzheimer’s disease.

Pipeline Progress and Scientific Presentations

  • AD/PD™ 2026 Presentations: ProMIS featured two key presentations at the Alzheimer’s Disease/Parkinson’s Disease International Conference highlighting the versatility of its discovery platform:
    • Dr. Neil Cashman, CSO, presented on the rational design of a vaccine against TDP-43 proteinopathies using a pathogenic epitope of misfolded TDP-43.
    • Dr. Johanne Kaplan, CDO, presented data on how vaccination with conformational epitopes derived from computational modeling elicits an active antibody response selective for toxic alpha-synuclein species.
  • Subcutaneous Formulation: The Company has accelerated the development of a subcutaneous formulation for PMN310 to enhance patient convenience and further strengthen the asset’s competitive profile.

Recent and Future Activities and Upcoming Milestones

  • Closed Private Placement: Completed a private placement in February 2026 for gross up-front proceeds of $75.5 million, with the potential to secure an additional $100 million upon exercise of warrants.
  • Bloom Burton & Co. Healthcare Investor Conference: Neil Warma, CEO, participated and presented a corporate overview. View here: PMN Corporate Overview
  • Fierce Biotech Week: Neil Warma, CEO, will participate in a panel discussion titled “Combination, Prevention, and New Biology in Neurodegenerative Drug Development”.
  • Alzheimer’s Association International Conference (AAIC): Poster presentation titled “Activity and clinical progress of PMN310 designed to selectively target toxic Aß oligomers for greater potency in Alzheimer’s disease” will be presented by Johanne Kaplan, Chief Development Officer. 
  • Interim Data Readout: Blinded interim analysis of PRECISE-AD safety and biomarker data anticipated early Q3 2026.
  • Top-line Results: Presentation of 12-month unblinded top-line data anticipated in early 2027.

Key Pipeline Programs

  • Development of subcutaneous formulation for PMN310
    • We have accelerated the development of a subcutaneous formulation of PMN310 and established a dedicated development plan, reflecting our conviction in the potential of this approach to improve patient experience and strengthen the asset’s competitive profile.
  • Amyotrophic Lateral Sclerosis Disease Program (PMN267)
    • PMN267 is the lead preclinical candidate antibody directed against toxic misfolded TDP-43 as a potential therapeutic target for ALS and other TDP-43 proteinopathies (e.g. frontotemporal dementia).  It has demonstrated strict selectivity for pathogenic TDP-43 and protective activity in antibody and intrabody formats.  PMN267 has been humanized in a human IgG1 framework for IND-enabling studies.
  • Parkinson’s Disease (PD), Dementia with Lewy Bodies and Multiple System Atrophy (MSA) Disease Program (PMN442)
    • ProMIS selected PMN442 as the lead candidate antibody for PD and other synucleinopathies based on its selective binding and protective activity against pathogenic forms of alpha-synuclein.  It has been humanized in a human IgG1 framework for IND-enabling studies.

First Quarter 2026 Financial Highlights

  • Cash Position: As of March 31, 2026, the Company’s cash and cash equivalents were $63.8 million, reflecting the $75.5 million in gross up-front proceeds from the February financing.
  • Cash Runway: Based on the current operating plan, existing cash resources are expected to fund planned operations through 2027, including the completion of the PRECISE-AD trial.
  • Net Loss: For the quarter ended March 31, 2026, the Company reported a net loss of $8.2 million, compared to a net loss of $7.3 million for the same period in 2025.

About ProMIS Neurosciences Inc.

ProMIS Neurosciences is a clinical-stage biotechnology company committed to the discovery and development of therapeutic antibodies and vaccines selective for toxic oligomers associated with the development and progression of neurodegenerative and other misfolded protein diseases. The Company’s proprietary target discovery engine, EpiSelect™, has been shown to predict novel targets known as Disease Specific Epitopes (DSEs) on the molecular surface of misfolded proteins that cause neurodegenerative and other misfolded protein diseases, including Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), multiple system atrophy (MSA), and Parkinson’s Disease (PD). ProMIS has offices in Cambridge, Massachusetts (USA) and Toronto, Ontario (CAN).

About PMN310 and the PRECISE-AD Trial for Alzheimer’s Disease (AD)

PMN310, the Company’s lead product candidate for the treatment of AD, is a humanized IgG1 monoclonal antibody that has been designed to selectively target only the toxic oligomers, avoiding plaque, thereby potentially reducing, or eliminating amyloid-related imaging abnormalities (ARIA) liability. In addition, because PMN310 may not be limited by off-target binding or side effects, PMN310 could potentially offer an improved efficacy profile over other amyloid-directed antibody therapeutics. PMN310 was granted Fast Track designation by the U.S. Food and Drug Administration in July 2025.

Based on the encouraging results from the Phase 1a trial (NCT06105528) of PMN310 in healthy volunteers, ProMIS initiated PRECISE-AD, a Phase 1b clinical trial in AD patients. PRECISE-AD (NCT06750432) is a randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability and pharmacokinetics (PK) of multiple ascending doses (5, 10, 20 mg/kg) of intravenous PMN310 in patients with Mild Cognitive Impairment due to AD or mild AD (Stage 3 and Stage 4 AD). PRECISE-AD will be the first study to examine the effects of a monoclonal antibody directed solely against Aβ oligomers on biomarkers associated with AD pathology and clinical outcomes. Safety will be a primary outcome of the study with particular emphasis on assessing whether, as a non-plaque binder, PMN310 may have a reduced risk of ARIA. The study is powered to provide 95% confidence for detection of ARIA and is designed to provide meaningful insight into the effects of PMN310 on biomarkers and clinical outcomes.

EpiSelect

TM

 Drug Discovery Engine

Toxic misfolded proteins underlie the pathogenesis of neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD). Generation of therapeutic antibodies selectively targeting only disease-misfolded protein isoforms, while sparing normal or irrelevant isoforms of the same protein, has not yet been successfully achieved by conventional immunization strategies. ProMIS Neurosciences has developed a computational platform (EpiSelect™) to identify conformational epitopes that are uniquely exposed on toxic misfolded proteins, which can then be used to generate misfolding-specific antibodies or vaccine formulations. Application of the ProMIS platform produced PMN310, a clinical stage, humanized monoclonal antibody candidate that has been shown to be highly selective for toxic amyloid-beta oligomers (AβO) without significant reactivity with amyloid-beta monomers or fibrils, thereby avoiding target distraction by these more abundant species, and potentially reducing the risk of brain edema and microhemorrhages associated with the targeting of vascular/parenchymal amyloid. Similarly, specific epitopes for alpha-synuclein toxic oligomers/soluble fibrils that drive synucleinopathies, and for pathogenic TDP-43 in ALS and FTD have been identified and lead candidate antibodies generated. The precise conformation of these epitopes has been translated into vaccines inducing an antibody response selective for pathogenic molecular species in preclinical mouse vaccination studies.

Forward-looking Statements

This press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Certain information in this news release constitutes forward-looking statements and forward-looking information (collectively, “forward-looking information”) within the meaning of applicable securities laws. In some cases, but not necessarily in all cases, forward-looking information can be identified by the ‎use of forward-looking terminology such as “plans”, “pleased to”, “look forward to”, “potential to”, “targets”, “expects” or “does not expect”, “is expected”, “excited about”, “an opportunity exists”, “is positioned”, “estimates”, “intends”, “assumes”, “expects”, “anticipates” or “does not anticipate” or “believes”, or variations of such words and ‎phrases or state that certain actions, events or results “may”, “could”, “would”, “might”, “will” or “will be taken”, “occur” or “be achieved”. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking information. Specifically, this news release contains forward-looking information relating to the Company’s Phase 1b study in AD patients, including planned timing for completion and anticipated data read out of interim results in the third quarter of 2026 and topline results by early 2027, statements relating to the Company’s progress, including enrollment and dosing for its Phase 1b clinical trial, the potential for PMN310 to positively benefit patients with AD, the targeting of toxic misfolded proteins in neurodegenerative diseases that the Company believes may directly address fundamental AD pathology (including the belief and understanding that toxic oligomers of Aß are a major driver of AD) and have greater therapeutic potential due to reduction of off-target activity, and the ability of the Company’s cash runway to fund operations through 2027. Statements containing forward-looking information are not historical facts but instead represent management’s current expectations, estimates and projections regarding the future of our business, future plans, strategies, projections, anticipated events and trends, the economy and other future conditions. Forward-looking information is necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by the Company as of the date of this news release, are subject to ‎known and unknown risks, uncertainties and assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including, but not limited to, including, but not limited to, the risk that preclinical results or early results may not be indicative of future results, its accumulated deficit and the expectation for continued losses and future financial results. Important factors that could cause actual results to differ materially from those indicated in the forward-looking information include, among others, the factors discussed throughout the “Risk Factors” section of the Copany’s most recently filed Annual Report on form-10-K for the year ended December 31, 2025 and in its subsequent filings filed with the United States Securities and Exchange Commission. Except as required by applicable securities laws, the Company undertakes no obligation to publicly update any forward-looking information, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Condensed Consolidated Balance Sheets (Unaudited)

               
    March 31,   December 31,  
      2026     2025  
Assets              
Current assets:              
Cash   $  63,814,345   $  6,116,556  
Short-term investments      33,753      33,753  
Prepaid expenses and other current assets      1,764,594      3,032,112  
Total current assets      65,612,692      9,182,421  
Prepaid expenses, long-term      1,798,879      —  
Total assets   $  67,411,571   $  9,182,421  
Liabilities and Shareholders’ Equity              
Current liabilities:              
Accounts payable   $  1,716,823   $  2,543,415  
Accrued liabilities      4,897,796      7,868,416  
Total current liabilities      6,614,619      10,411,831  
Share-based compensation liability      79,380      29,182  
Total liabilities      6,693,999      10,441,013  
               
Shareholders’ equity:              
Common Shares, no par value, unlimited shares authorized, 8,967,693 and 2,152,397 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively      —      —  
Additional paid-in capital      199,739,348      129,518,812  
Accumulated other comprehensive loss      (371,184)      (371,184)  
Accumulated deficit      (138,650,592)      (130,406,220)  
Total shareholders’ equity      60,717,572      (1,258,592)  
Total liabilities and shareholders’ equity   $  67,411,571   $  9,182,421  

Condensed Consolidated Statement of Operations (Unaudited)

               
    For the   For the  
    Three Months Ended   Three Months Ended  
    March 31,   March 31,  
      2026     2025  
Operating expenses:              
Research and development   $  6,971,005   $  5,464,250  
General and administrative      1,673,890      1,995,845  
Total operating expenses      8,644,895      7,460,095  
Loss from operations      (8,644,895)      (7,460,095)  
               
Other income      400,523      112,192  
               
Net loss   $  (8,244,372)   $  (7,347,903)  
               
Net loss per share, basic and diluted   $  (1.26)   $  (5.27)  
               
Weighted-average outstanding Common Shares, basic and diluted      6,527,779      1,394,048  

For Investor Relations, please contact:

Carie Pierce VP, Investor Relations & External Affairs

[email protected]



Zebra Technologies Announces First-Quarter 2026 Results

Zebra Technologies Announces First-Quarter 2026 Results

Delivers strong first-quarter 2026 performance with broad-based growth across segments and regions

Increases outlook for the full year 2026

LINCOLNSHIRE, Ill.–(BUSINESS WIRE)–Zebra Technologies Corporation (NASDAQ: ZBRA), a global leader in digitizing and automating workflows to deliver intelligent operations, today announced results for the first quarter ended April 4, 2026.

First-Quarter Financial Highlights

  • Net sales of $1,495 million; year-over-year increase of 14.3%

  • Net income of $135 million and net income per diluted share of $2.72

  • Non-GAAP diluted EPS increased year-over-year to $4.75

  • Adjusted EBITDA increased year-over-year to $347 million

  • Share repurchases of $300 million

“Our strong first quarter results demonstrate the durability of demand for our innovative technology, with organic growth across our segments and regions, led by strength in our manufacturing end market. Elo Touch also contributed solid profitable growth as we begin to drive synergies,” said Bill Burns, Chief Executive Officer of Zebra Technologies. “These results underscore the value Zebra delivers as the foundation for intelligent operations across the frontline, helping customers operate more efficiently and effectively.”

“We are building on our track record of value creation for shareholders with $300 million of share repurchases in each of the past two quarters, supported by our strong balance sheet and cash flow,” said Nathan Winters, Chief Financial Officer of Zebra Technologies. “Our results reflect our focus on profitable growth, operating discipline and margin expansion, and we remain confident in our ability to support customer demand while delivering consistent performance in a dynamic environment.”

$ in millions, except per share amounts

 

1Q26

 

 

1Q25

 

Change

Select reported measures:

 

 

 

Net sales

$

1,495

 

$

1,308

 

14.3

%

Gross profit

 

742

 

 

645

 

15.0

%

Gross margin

 

49.6

%

 

49.3

%

30 bps

Net income

 

135

 

 

136

 

(0.7

%)

Net income margin

 

9.0

%

 

10.4

%

(140) bps

Net income per diluted share

$

2.72

 

$

2.62

 

3.8

%

 

 

 

 

Select Non-GAAP measures:

 

 

 

Adjusted net sales

$

1,495

 

$

1,308

 

14.3

%

Organic net sales growth

 

 

4.3

%

Adjusted gross profit

 

753

 

 

649

 

16.0

%

Adjusted gross margin

 

50.4

%

 

49.6

%

80 bps

Adjusted EBITDA

 

347

 

 

292

 

18.8

%

Adjusted EBITDA margin

 

23.2

%

 

22.3

%

90 bps

Non-GAAP net income

$

235

 

$

208

 

13.0

%

Non-GAAP earnings per diluted share

$

4.75

 

$

4.02

 

18.2

%

Net sales were $1,495 million in the first quarter of 2026 compared to $1,308 million in the prior year. Net sales in the Connected Frontline (“CF”) segment were $825 million in the first quarter of 2026 compared to $684 million in the prior year. Asset Visibility & Automation (“AVA”) segment net sales were $670 million in the first quarter of 2026 compared to $624 million in the prior year. Consolidated organic net sales for the first quarter of 2026 increased 4.3% year-over-year, with a 3.8% increase in the CF segment and a 4.8% increase in the AVA segment.

First quarter 2026 gross profit was $742 million compared to $645 million in the prior year. Gross margin increased to 49.6% for the first quarter of 2026 compared to 49.3% in the prior year primarily due to favorable foreign currency exchange and business mix, and productivity initiatives. Adjusted gross margin was 50.4% in the first quarter of 2026 compared to 49.6% in the prior year.

Operating expenses increased to $527 million in the first quarter of 2026 from $450 million in the prior year primarily due to expenses associated with acquired businesses including amortization of intangible assets. Adjusted operating expenses increased to $425 million in the first quarter of 2026 from $374 million in the prior year.

Net income for the first quarter of 2026 was $135 million, or $2.72 per diluted share, compared to net income of $136 million, or $2.62 per diluted share, in the prior year. Non-GAAP net income increased to $235 million for the first quarter of 2026, or $4.75 per diluted share, compared to $208 million, or $4.02 per diluted share, for the prior year.

Adjusted EBITDA for the first quarter of 2026 increased to $347 million, or 23.2% of adjusted net sales, compared to $292 million, or 22.3% of adjusted net sales in the prior year due to higher gross margin and lower adjusted operating expense as a percentage of sales.

Balance Sheet and Cash Flow

As of April 4, 2026, the Company had cash and cash equivalents of $114 million and total debt of $2,660 million.

For the first three months of 2026, net cash provided by operating activities was $176 million and the Company invested $13 million in capital expenditures, resulting in free cash flow of $163 million. The Company also made share repurchases of $300 million.

Outlook

Mr. Burns added, “We are seeing continued momentum into the second quarter, supporting our increased outlook for the full year. Zebra’s integrated portfolio of solutions is a key differentiator, enabling customers to connect data, assets and workflows to drive visibility and productivity. As e-commerce, automation and Physical AI trends accelerate, we are well positioned to drive profitable growth, build on our market leadership and innovation, and strengthen our financial position to deliver long-term shareholder value.”

Second Quarter 2026

The Company expects second quarter sales growth between 14% and 17% compared to the prior year. This expectation includes approximately 10.5 points of favorable net impact from business acquisitions and foreign currency.

Adjusted EBITDA margin for the second quarter is expected to be slightly higher than 21%. Non-GAAP diluted earnings per share are expected to be in the range of $4.20 to $4.50. This assumes an adjusted effective tax rate of approximately 19%.

Full Year 2026

The Company expects full year sales growth between 10% and 14% compared to the prior year. This expectation includes approximately 7 points of favorable net impact from business acquisitions and foreign currency.

Adjusted EBITDA margin for the full year is expected to be approximately 22%. Non-GAAP diluted earnings per share are expected to be in the range of $18.30 to $18.70. This assumes an adjusted effective tax rate of approximately 19%.

Free Cash Flow for the full year is expected to be greater than $900 million.

The Company does not provide a reconciliation for non-GAAP estimates on a forward-looking basis where it is unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing or amount of the most directly comparable forward-looking GAAP financial measure as discussed under the “Forward-Looking Statements” caption below. This would include items that have not yet occurred, are out of the Company’s control and/or cannot be reasonably predicted, and that would impact diluted net earnings per share. For the same reasons, the Company is unable to address the probable significance of the unavailable information. Forward-looking non-GAAP financial measures provided without the most directly comparable GAAP financial measures may vary materially from the corresponding GAAP financial measures.

Conference Call Notification

Investors are invited to listen to a live webcast of Zebra’s conference call regarding the Company’s financial results. The conference call will be held today at 7:30 a.m. Central Time (8:30 a.m. Eastern Time). To view the webcast, visit the investor relations section of the Company’s website at investors.zebra.com.

Who is Zebra Technologies

Zebra (NASDAQ: ZBRA) provides the foundation for intelligent operations with an award-winning portfolio of connected frontline, asset visibility and automation solutions which empower our customers to deploy AI on the frontline. Organizations globally across retail, manufacturing, transportation, logistics, healthcare, and other industries rely on us to deliver outcomes today while driving innovation for what’s next. Together with our partners, we create new ways of working that improve productivity and empower organizations to be better every day. Learn more at www.zebra.com.

Follow Zebra on our Blog, LinkedIn, Facebook, X, Instagram and YouTube.

Forward-Looking Statements

This press release contains forward-looking statements, as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation, the statements regarding the company’s outlook. Actual results may differ from those expressed or implied in the company’s forward-looking statements. These statements represent estimates only as of the date they were made. Zebra undertakes no obligation, other than as may be required by law, to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changed circumstances or any other reason after the date of this release.

These forward-looking statements are based on current expectations, forecasts and assumptions and are subject to the risks and uncertainties inherent in Zebra’s industry, market conditions, general domestic and international economic conditions, and other factors. These factors include customer acceptance of Zebra’s offerings and competitors’ offerings, and the potential effects of emerging technologies and changes in customer requirements. The effect of global market conditions, and the availability of credit and capital markets volatility may have adverse effects on Zebra, its suppliers and its customers. In addition, natural disasters, man-made disasters, public health issues (including pandemics), and cybersecurity incidents may have negative effects on Zebra’s business and results of operations. Zebra’s ability to purchase sufficient materials, parts, and components, and ability to provide services, software and products to meet customer demand could negatively impact Zebra’s results of operations and customer relationships. Profits and profitability will be affected by Zebra’s ability to control manufacturing and operating costs. Because of its debt, interest rates and financial market conditions may also have an adverse impact on results. Foreign exchange rates, customs duties and trade policies may have an adverse effect on financial results because of the global nature of Zebra’s business. The impacts of changes in foreign and domestic governmental policies, regulations, or laws, as well as the outcome of litigation or tax matters in which Zebra may be involved are other factors that could adversely affect Zebra’s business and results of operations. The success of integrating acquisitions could also adversely affect profitability, reported results and the company’s competitive position in its industry. These and other factors could have an adverse effect on Zebra’s sales, gross profit margins and results of operations and increase the volatility of Zebra’s financial results. When used in this release and documents referenced, the words “anticipate,” “believe,” “outlook,” and “expect” and similar expressions, as they relate to the Company or its management, are intended to identify such forward-looking statements, but are not the exclusive means of identifying these statements. Descriptions of certain risks, uncertainties and other factors that could adversely affect the Company’s future operations and results can be found in Zebra’s filings with the Securities and Exchange Commission, including the Company’s most recent Form 10-K and Form 10-Q.

Use of Non-GAAP Financial Information

This press release contains certain Non-GAAP financial measures, consisting of “Adjusted EBITDA,” “Adjusted EBITDA margin,” “adjusted gross margin,” “adjusted gross profit,” “adjusted net sales,” “adjusted operating expenses,” “adjusted operating income,” “EBITDA,” “free cash flow,” “non-GAAP diluted earnings per share,” “non-GAAP earnings per share,” “non-GAAP net income,” “organic net sales,” and “organic net sales growth.” Management presents these measures to focus on the on-going operations and believes it is useful to investors because they enable them to perform meaningful comparisons of past and present operating results. The company believes it is useful to present non-GAAP financial measures, which exclude certain significant items, as a means to understand the performance of its ongoing operations and how management views the business. Please see the “Reconciliation of GAAP to Non-GAAP Financial Measures” tables and accompanying disclosures at the end of this press release for more detailed information regarding non-GAAP financial measures herein, including the items reflected in adjusted net earnings calculations. These measures, however, should not be construed as an alternative to any other measure of performance determined in accordance with GAAP.

The company does not provide a reconciliation for non-GAAP estimates on a forward-looking basis (including the information under “Outlook” above) where it is unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing or amount of various items that have not yet occurred, are out of the company’s control and/or cannot be reasonably predicted, and that would impact diluted net earnings per share, the most directly comparable forward-looking GAAP financial measure. For the same reasons, the company is unable to address the probable significance of the unavailable information. Forward-looking non-GAAP financial measures provided without the most directly comparable GAAP financial measures may vary materially from the corresponding GAAP financial measures.

As a global company, Zebra’s operating results reported in U.S. dollars are affected by foreign currency exchange rate fluctuations because the underlying foreign currencies in which the company transacts change in value over time compared to the U.S. dollar; accordingly, the company presents certain organic growth financial information, which includes impacts of foreign currency translation, to provide a framework to assess how the company’s businesses performed excluding the impact of foreign currency exchange rate fluctuations. Foreign currency impact represents the difference in results that are attributable to fluctuations in the currency exchange rates used to convert the results for businesses where the functional currency is not the U.S. dollar. This impact is calculated by translating current period results at the currency exchange rates used in the comparable prior year period as well as removing realized cash flow hedge gains and losses from both the current and prior year periods. The company believes these measures should be considered a supplement to and not in lieu of the company’s performance measures calculated in accordance with GAAP.

ZEBRA TECHNOLOGIES CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In millions, except per share data)

 

 

April 4,

2026

 

December 31,

2025

 

(Unaudited)

 

 

Assets

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

114

 

 

$

125

 

Accounts receivable, net of allowances for doubtful accounts of $1 million each as of April 4, 2026 and December 31, 2025

 

733

 

 

 

801

 

Inventories, net

 

692

 

 

 

729

 

Income tax receivable

 

30

 

 

 

31

 

Prepaid expenses and other current assets

 

126

 

 

 

110

 

Total Current assets

 

1,695

 

 

 

1,796

 

Property, plant and equipment, net

 

350

 

 

 

353

 

Right-of-use lease assets

 

170

 

 

 

166

 

Goodwill

 

4,709

 

 

 

4,727

 

Other intangibles, net

 

765

 

 

 

809

 

Deferred income taxes

 

410

 

 

 

414

 

Other long-term assets

 

233

 

 

 

237

 

Total Assets

$

8,332

 

 

$

8,502

 

Liabilities and Stockholders’ Equity

 

 

 

Current liabilities:

 

 

 

Current portion of long-term debt

$

264

 

 

$

141

 

Accounts payable

 

581

 

 

 

695

 

Accrued liabilities

 

459

 

 

 

558

 

Deferred revenue

 

434

 

 

 

446

 

Income taxes payable

 

25

 

 

 

12

 

Total Current liabilities

 

1,763

 

 

 

1,852

 

Long-term debt

 

2,387

 

 

 

2,361

 

Long-term lease liabilities

 

158

 

 

 

157

 

Deferred income taxes

 

32

 

 

 

32

 

Long-term deferred revenue

 

398

 

 

 

396

 

Other long-term liabilities

 

124

 

 

 

116

 

Total Liabilities

 

4,862

 

 

 

4,914

 

Stockholders’ Equity:

 

 

 

Preferred stock, $.01 par value; authorized 10,000,000 shares; none issued

 

 

 

 

 

Class A common stock, $.01 par value; authorized 150,000,000 shares; issued 72,151,857 shares

 

1

 

 

 

1

 

Additional paid-in capital

 

866

 

 

 

814

 

Treasury stock at cost, 23,768,847 and 22,558,911 shares as of April 4, 2026 and December 31, 2025, respectively

 

(2,787

)

 

 

(2,488

)

Retained earnings

 

5,414

 

 

 

5,279

 

Accumulated other comprehensive loss

 

(24

)

 

 

(18

)

Total Stockholders’ Equity

 

3,470

 

 

 

3,588

 

Total Liabilities and Stockholders’ Equity

$

8,332

 

 

$

8,502

 

ZEBRA TECHNOLOGIES CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(In millions, except share data)

(Unaudited)

 

 

Three Months Ended

 

April 4,

2026

 

March 29,

2025

Net sales:

 

 

 

Tangible products

$

1,231

 

 

$

1,062

 

Services and software

 

264

 

 

 

246

 

Total Net sales

 

1,495

 

 

 

1,308

 

Cost of sales:

 

 

 

Tangible products

 

623

 

 

 

542

 

Services and software

 

130

 

 

 

121

 

Total Cost of sales

 

753

 

 

 

663

 

Gross profit

 

742

 

 

 

645

 

Operating expenses:

 

 

 

Selling and marketing

 

189

 

 

 

161

 

Research and development

 

165

 

 

 

151

 

General and administrative

 

127

 

 

 

111

 

Amortization of intangible assets

 

37

 

 

 

24

 

Acquisition and integration costs

 

1

 

 

 

3

 

Exit and restructuring costs

 

8

 

 

 

 

Total Operating expenses

 

527

 

 

 

450

 

Operating income

 

215

 

 

 

195

 

Other (loss) income, net:

 

 

 

Foreign exchange loss

 

 

 

 

(5

)

Interest expense, net

 

(37

)

 

 

(23

)

Other expense, net

 

(11

)

 

 

(2

)

Total Other expense, net

 

(48

)

 

 

(30

)

Income before income tax

 

167

 

 

 

165

 

Income tax expense

 

32

 

 

 

29

 

Net income

$

135

 

 

$

136

 

Basic earnings per share

$

2.74

 

 

$

2.64

 

Diluted earnings per share

$

2.72

 

 

$

2.62

 

ZEBRA TECHNOLOGIES CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In millions)

(Unaudited)

 

 

Three Months Ended

 

April 4,

2026

 

March 29,

2025

Cash flows from operating activities:

 

 

 

Net income

$

135

 

 

$

136

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

Depreciation and amortization

 

56

 

 

 

41

 

Loss on sale of investments

 

15

 

 

 

 

Share-based compensation

 

58

 

 

 

51

 

Deferred income taxes

 

 

 

 

(23

)

Gain on sale of business

 

(5

)

 

 

 

Other, net

 

1

 

 

 

1

 

Changes in operating assets and liabilities:

 

 

 

Accounts receivable, net

 

67

 

 

 

84

 

Inventories, net

 

34

 

 

 

15

 

Other assets

 

(12

)

 

 

3

 

Accounts payable

 

(119

)

 

 

(76

)

Accrued liabilities

 

(67

)

 

 

(110

)

Deferred revenue

 

(11

)

 

 

16

 

Income taxes

 

24

 

 

 

42

 

Other operating activities

 

 

 

 

(2

)

Net cash provided by operating activities

 

176

 

 

 

178

 

Cash flows from investing activities:

 

 

 

Acquisition of business

 

 

 

 

(62

)

Proceeds from the sale of business

 

9

 

 

 

 

Purchases of property, plant and equipment

 

(13

)

 

 

(20

)

Proceeds from sale of long-term investments

 

1

 

 

 

 

Other investing activities

 

1

 

 

 

 

Net cash used in investing activities

 

(2

)

 

 

(82

)

Cash flows from financing activities:

 

 

 

Payments of debt

 

(37

)

 

 

 

Proceeds from issuance of debt

 

186

 

 

 

 

Payments for repurchases of common stock

 

(300

)

 

 

(125

)

Net payments related to share-based compensation plans

 

(5

)

 

 

(1

)

Change in unremitted cash collections from servicing factored receivables

 

(29

)

 

 

2

 

Other financing activities

 

 

 

 

5

 

Net cash used in financing activities

 

(185

)

 

 

(119

)

Effect of exchange rate changes on cash and cash equivalents

 

 

 

 

1

 

Net decrease in cash and cash equivalents

 

(11

)

 

 

(22

)

Cash and cash equivalents at beginning of period

 

125

 

 

 

901

 

Cash and cash equivalents at end of period

$

114

 

 

$

879

 

Supplemental disclosures of cash flow information:

 

 

 

Income taxes paid

$

15

 

 

$

9

 

Interest paid

$

26

 

 

$

16

 

ZEBRA TECHNOLOGIES CORPORATION AND SUBSIDIARIES

RECONCILIATION OF ORGANIC NET SALES GROWTH

(Unaudited)

 

 

Three Months Ended

 

April 4, 2026

 

CF

 

AVA

 

Consolidated

Consolidated Reported GAAP Net sales growth

20.6

%

 

7.4

%

 

14.3

%

Adjustments:

 

 

 

 

 

Impact of foreign currency translations (1)

(2.1

)%

 

(2.2

)%

 

(2.1

)%

Impact of acquisitions (2)

(14.7

)%

 

(0.4

)%

 

(7.9

)%

Consolidated Organic Net sales growth

3.8

%

 

4.8

%

 

4.3

%

(1)

Operating results reported in U.S. Dollars are affected by foreign currency exchange rate fluctuations. Foreign currency translation impact represents the difference in results that are attributable to fluctuations in the currency exchange rates used to convert the results for businesses where the functional currency is not the U.S. Dollar. This impact is calculated by translating the current period results at the currency exchange rates used in the comparable prior year period as well as removing realized cash flow hedge gains and losses from both the current and prior year periods.

 

(2)

For purposes of computing Organic Net sales growth, amounts attributable to business acquisitions or dispositions are excluded for twelve months following or preceding the respective acquisition or disposition, respectively.

ZEBRA TECHNOLOGIES CORPORATION AND SUBSIDIARIES

RECONCILIATION OF GAAP TO NON-GAAP GROSS MARGIN AND OPERATING INCOME

($ In millions)

(Unaudited)

 

 

Three Months Ended

 

April 4, 2026

 

March 29, 2025

 

CF

 

AVA

 

Consolidated

 

CF

 

AVA

 

Consolidated

GAAP

 

 

 

 

 

 

 

 

 

 

 

Reported Net sales

$

825

 

 

$

670

 

 

$

1,495

 

 

$

684

 

 

$

624

 

 

$

1,308

 

Reported Gross profit (1)

 

405

 

 

 

348

 

 

 

742

 

 

 

333

 

 

 

316

 

 

 

645

 

Gross Margin

 

49.1

%

 

 

51.9

%

 

 

49.6

%

 

 

48.7

%

 

 

50.6

%

 

 

49.3

%

Operating Income (2)

 

169

 

 

 

159

 

 

 

215

 

 

 

140

 

 

 

135

 

 

 

195

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP

 

 

 

 

 

 

 

 

 

 

 

Adjusted Net sales

$

825

 

 

$

670

 

 

$

1,495

 

 

$

684

 

 

$

624

 

 

$

1,308

 

Adjusted Gross profit (1)

 

405

 

 

 

348

 

 

 

753

 

 

 

333

 

 

 

316

 

 

 

649

 

Adjusted Gross Margin

 

49.1

%

 

 

51.9

%

 

 

50.4

%

 

 

48.7

%

 

 

50.6

%

 

 

49.6

%

Adjusted Operating Income (2)

 

169

 

 

 

159

 

 

 

328

 

 

 

140

 

 

 

135

 

 

 

275

 

(1)

Segment and Adjusted Gross profit excludes share-based compensation expense and business acquisition purchase accounting adjustments.

(2)

Segment and Non-GAAP Operating income excludes share-based compensation expense, business acquisition purchase accounting adjustments, amortization of intangible assets, acquisition and integration costs, exit and restructuring costs, as well as certain other non-recurring costs (impairment of goodwill and other intangible assets).

ZEBRA TECHNOLOGIES CORPORATION AND SUBSIDIARIES

RECONCILIATION OF GAAP TO NON-GAAP NET INCOME

($ In millions, except share data)

(Unaudited)

 

 

Three Months Ended

 

April 4,

2026

 

March 29,

2025

GAAP Net income

$

135

 

 

$

136

 

Adjustments to Cost of sales(1)

 

 

 

Purchase accounting adjustments

 

5

 

 

 

 

Share-based compensation

 

6

 

 

 

4

 

Total adjustments to Cost of sales

 

11

 

 

 

4

 

Adjustments to Operating expenses(1)

 

 

 

Amortization of intangible assets

 

37

 

 

 

24

 

Acquisition and integration costs

 

1

 

 

 

3

 

Share-based compensation

 

56

 

 

 

49

 

Exit and restructuring costs

 

8

 

 

 

 

Total adjustments to Operating expenses

 

102

 

 

 

76

 

Adjustments to Other expense, net(1)

 

 

 

Amortization of debt issuance costs and discounts

 

1

 

 

 

1

 

Loss on sale of investments

 

15

 

 

 

 

Foreign exchange loss

 

 

 

 

5

 

Gain on sale of business

 

(5

)

 

 

Total adjustments to Other expense, net

 

11

 

 

 

6

 

Income tax effect of adjustments(2)

 

 

 

Reported income tax expense

 

32

 

 

 

29

 

Adjusted income tax

 

(56

)

 

 

(43

)

Total adjustments to income tax

 

(24

)

 

 

(14

)

Total adjustments

 

100

 

 

 

72

 

Non-GAAP Net income

$

235

 

 

$

208

 

 

 

 

 

GAAP earnings per share

 

 

 

Basic

$

2.74

 

 

$

2.64

 

Diluted

$

2.72

 

 

$

2.62

 

Non-GAAP earnings per share

 

 

 

Basic

$

4.79

 

 

$

4.06

 

Diluted

$

4.75

 

 

$

4.02

 

 

 

 

 

Basic weighted average shares outstanding

 

49,017,288

 

 

 

51,365,011

 

Diluted weighted average and equivalent shares outstanding

 

49,428,337

 

 

 

51,806,550

 

(1)

Presented on a pre-tax basis.

(2)

Represents adjustments to GAAP income tax expense commensurate with pre-tax non-GAAP adjustments (including the resulting impacts to U.S. BEAT/GILTI provisions), as well as adjustments to exclude the impacts of certain discrete income tax items and incorporate the anticipated annualized effects of current year tax planning.

ZEBRA TECHNOLOGIES CORPORATION AND SUBSIDIARIES

GAAP to NON-GAAP RECONCILIATION TO EBITDA

($ In millions)

(Unaudited)

 

 

Three Months Ended

 

April 4,

2026

 

March 29,

2025

GAAP Net income

$

135

 

 

$

136

 

Add back:

 

 

 

Depreciation (excluding exit and restructuring)

 

19

 

 

 

17

 

Amortization of intangible assets

 

37

 

 

 

24

 

Total Other expense, net

 

48

 

 

 

30

 

Income tax expense

 

32

 

 

 

29

 

EBITDA (Non-GAAP)

 

271

 

 

 

236

 

 

 

 

 

Adjustments to Cost of sales

 

 

 

Purchase accounting adjustments

 

5

 

 

 

 

Share-based compensation

 

6

 

 

 

4

 

Total adjustments to Cost of sales

 

11

 

 

 

4

 

Adjustments to Operating expenses

 

 

 

Acquisition and integration costs

 

1

 

 

 

3

 

Share-based compensation

 

56

 

 

 

49

 

Exit and restructuring costs

 

8

 

 

 

 

Total adjustments to Operating expenses

 

65

 

 

 

52

 

Total adjustments to EBITDA

 

76

 

 

 

56

 

Adjusted EBITDA (Non-GAAP)

$

347

 

 

$

292

 

 

 

 

 

Adjusted EBITDA margin (Non-GAAP)

 

23.2

%

 

 

22.3

%

FREE CASH FLOW

 

 

Three Months Ended

 

April 4,

2026

 

March 29,

2025

Net cash provided by operating activities

$

176

 

 

$

178

 

Less: Purchases of property, plant and equipment

 

(13

)

 

 

(20

)

Free cash flow (Non-GAAP)(1)

$

163

 

 

$

158

 

 

(1) Free cash flow, a non-GAAP measure, is defined as Net cash provided by (used in) operating activities in a period minus purchases of property, plant and equipment (capital expenditures) made in that period.

 

Investors

Michael Steele, CFA, IRC

Vice President, Investor Relations

Phone: + 1 847 518 6432

[email protected]

Media

Therese Van Ryne

Senior Director, External Communications

Phone: + 1 847 370 2317

[email protected]

KEYWORDS: Illinois United States North America

INDUSTRY KEYWORDS: Data Management Technology Other Technology Software Networks Artificial Intelligence Internet

MEDIA:

Logo
Logo

Parsons Awarded Position on $136 Million Air Force Contract

CHANTILLY, Va., May 12, 2026 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) announced today that the company was selected by the United States Air Force (USAF) and its 75th Civil Engineer Group at Hill Air Force Base for a multiple award task order contract (MATOC) to provide architect-engineer services across the installation. The $136 million ceiling value contract consists of an 8.5-year performance period and represents new work for the company.

Under the contract, Parsons will compete for task orders to deliver architect-engineer services supporting a range of infrastructure needs at Hill AFB. The scope of work includes the design, alteration, and repair of airfields, grounds, roads, buildings, structures, and utilities, as well as feasibility and traffic studies and cybersecurity-related design services that support secure, resilient installation operations.

“This award reflects the Air Force’s continued trust in Parsons’ ability to support complex, mission-critical infrastructure programs through disciplined design and engineering services,” said Martin Boson, president, Engineered Systems for Parsons. “By combining multidisciplinary engineering expertise with an agile delivery mindset, we look forward to supporting the 75th Civil Engineer Group in maintaining and modernizing facilities that are essential to mission readiness for the Department of War.”

Parsons has an extensive history of supporting the Air Force through architect-engineer and infrastructure services that enable installation modernization and sustainment. The company provides disciplined planning, design, and engineering expertise to support operations, facilities sustainment, and utility systems critical to mission execution. By aligning technical design excellence with installation priorities, Parsons helps the USAF modernize infrastructure while maintaining operational continuity. Beyond infrastructure solutions, the company provides all-domain support to the Air Force with agile, scalable solutions spanning cyber, electronic warfare, space, and advanced technology systems.

To learn more about Parsons’ federal infrastructure solutions, visit parsons.com/federal-infrastructure/.

About Parsons

Parsons (NYSE: PSN) is a leading disruptive technology provider in the national security and global infrastructure markets, with capabilities across cyber and electronic warfare, space and missile defense, transportation, water and environment, urban development, and critical infrastructure protection. Please visit


Parsons.com


and follow us on


LinkedIn


to learn how we’re making an impact.

Media Contact:
Bernadette Miller
+1 980.253.9781
[email protected]

Investor Relations Contact:
Dave Spille
+1 703.775.6191
[email protected]

Forward-Looking Statements:

This document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are based on our current expectations, beliefs and assumptions, and are not guarantees of future performance. Forward-looking statements are inherently subject to uncertainties, risks, changes in circumstances, trends and factors that are difficult to predict, many of which are outside of our control. Accordingly, actual performance, results and events may vary materially from those indicated in the forward-looking statements, and you should not rely on the forward-looking statements as predictions of future performance, results or events. Numerous factors could cause actual future performance, results and events to differ materially from those indicated in the forward-looking statements, including, among others: any issue that compromises our relationships with the U.S. federal government or its agencies or other state, local or foreign governments or agencies; any issues that damage our professional reputation; changes in governmental priorities that shift expenditures away from agencies or programs that we support; our dependence on long-term government contracts, which are subject to the government’s budgetary approval process; the size of our addressable markets and the amount of government spending on private contractors; failure by us or our employees to obtain and maintain necessary security clearances or certifications; failure to comply with numerous laws and regulations; changes in government procurement, contract or other practices or the adoption by governments of new laws, rules, regulations and programs in a manner adverse to us; the termination or nonrenewal of our government contracts, particularly our contracts with the U.S. federal government; our ability to compete effectively in the competitive bidding process and delays, contract terminations or cancellations caused by competitors’ protests of major contract awards received by us; our ability to generate revenue under certain of our contracts; any inability to attract, train or retain employees with the requisite skills, experience and security clearances; the loss of members of senior management or failure to develop new leaders; misconduct or other improper activities from our employees or subcontractors; our ability to realize the full value of our backlog and the timing of our receipt of revenue under contracts included in backlog; changes in the mix of our contracts and our ability to accurately estimate or otherwise recover expenses, time and resources for our contracts; changes in estimates used in recognizing revenue; internal system or service failures and security breaches; and inherent uncertainties and potential adverse developments in legal proceedings, including litigation, audits, reviews and investigations, which may result in materially adverse judgments, settlements or other unfavorable outcomes. These factors are not exhaustive and additional factors could adversely affect our business and financial performance. For a discussion of additional factors that could materially adversely affect our business and financial performance, see the factors included under the caption “Risk Factors” in our Registration Statement on Form S-1 and our other filings with the Securities and Exchange Commission. All forward-looking statements are based on currently available information and speak only as of the date on which they are made. We assume no obligation to update any forward-looking statement made in this presentation that becomes untrue because of subsequent events, new information or otherwise, except to the extent we are required to do so in connection with our ongoing requirements under federal securities laws.



Aramark Reports Second Quarter Earnings

Aramark Reports Second Quarter Earnings

YEAR-OVER-YEAR SUMMARY

Note: As previously disclosed, the calendar shift resulting from the 53rd week in fiscal 2025 affects quarterly comparisons in fiscal 2026

  • Revenue +15%; Organic Revenue +12%
    • Performance led by broad-based net new business and base business growth in both FSS United States and International; Approximately 3% benefit to Revenue and Organic Revenue growth from the calendar shift

    • New business wins have already reached a record $1 billion this fiscal year to date; High client retention rate exceeding 98% across the Company

  • Operating Income +26%; Adjusted Operating Income (AOI) +24%1
    • Enhanced technology capabilities resulted in additional productivity gains; Approximately 14% and 12% benefit to Operating Income and AOI growth, respectively, from the calendar shift

    • Profitability growth reflected strong revenue levels, supply chain efficiencies, and effective above-unit cost management

  • GAAP EPS +65% to $0.38; Adjusted EPS +40%1 to $0.49
    • Continued momentum in top and bottom line financial performance; Approximately 30% and 20% benefit to GAAP EPS and Adjusted EPS growth, respectively, from the calendar shift

    • Favorable business trends occurring throughout the organization

  • Disciplined Capital Allocation Priorities Contributed to Strong Cash Flow
    • Net cash provided by operating activities of $400 million, +56%; Free Cash Flow of $305 million, +116%, with more than $1.4 billion in cash availability

    • Proactively repaid $55 million of 2030 Term Loans; Repurchased approximately $25 million of stock

  • Recently Entered Hyperscale AI Data Center Market Offering Integrated Suite of Capabilities
    • Launched Aramark Nexus, a new platform delivering hospitality and workforce support services for hyperscale AI data centers and other large-scale, complex, and often remote operating environments

    • New multi-year agreement with a top global hyperscaler underway; Significant pipeline of growth opportunities for Aramark Nexus

PHILADELPHIA–(BUSINESS WIRE)–
Aramark (NYSE: ARMK) today reported second quarter fiscal 2026 results.

1

On a constant currency basis

“Our financial results underscore the continued momentum at the Company driven by our unwavering focus on delivering hospitality excellence,” said John Zillmer, Aramark’s Chief Executive Officer. “With exceptionally strong business trends across sectors and geographies, we’ve updated our fiscal 2026 Outlook to the high end of our previously stated expectations for Organic Revenue growth. This reflects our team’s disciplined execution of our growth strategies as we continue to achieve new milestones.”

“We’re excited about our entry into the hyperscale AI data center market with the launch of Aramark Nexus™ where we bring proven expertise in highly complex operations and an established competitive advantage. As we execute on our new multi-year engagement with a top global hyperscaler, this client is expected to become the largest in our portfolio. We believe there is substantial growth potential with this client and other hyperscalers, combined with the existing sales momentum occurring throughout our broader portfolio.”

SECOND QUARTER RESULTS

Consolidated revenue was $4.9 billion in the second quarter, a 15% increase year-over-year. The favorable effect of currency translation increased revenue by approximately $101 million. Organic Revenue, which excludes the effect of currency translation, was higher by 12% compared to the same year-ago period. Growth was led by broad-based net new business and base business expansion across sectors and geographies. The calendar shift from the 53rd week in the prior year increased Revenue and Organic Revenue growth by an estimated 3%, principally in the Education sector within the FSS United States segment.

 

Revenue

 

 

Q2 ’26

Q2 ’25

Change (%)

 

Organic Revenue

Change (%)

 

FSS United States

$3,430M

$3,056M

12 %

 

12 %

 

FSS International

1,477

1,223

21 %

 

13 %

 

Total Company

$4,907M

$4,279M

15 %

 

12 %

 

May not total due to rounding

Difference between Change (%) and Organic Revenue Change (%) is the effect of currency translation

  • FSS United States revenue growth was led by 1) Sports, Leisure & Corrections primarily from higher per cap spending and attendance levels in Sports & Entertainment, which included Opening Day of Major League Baseball and the World Baseball Classic, as well as the NCAA Basketball Tournament; 2) Business & Industry from sustained double-digit growth with significant new business contribution, exceptionally high client retention rates, elevated catering demand, and an expanded Refreshments client base; and 3) Healthcare from onboarding new business. Revenue and Organic Revenue growth also benefited by approximately 4% from the calendar shift.

  • FSS International revenue growth was across all geographies, driven by ongoing base business expansion and net new business performance—which included double-digit growth in both Europe and Canada, and Emerging Markets experiencing high-single digit growth on an organic basis. The calendar shift positively affected Revenue and Organic Revenue growth by an estimated 1%. Revenue on a GAAP basis included the favorable effect of currency translation.

Operating Income was $220 million, an increase of 26% compared to the prior year period, and AOI grew 24%1 to $258 million. The quarter benefited from higher revenue levels, productivity gains in food and labor, supply chain efficiencies, and effective above-unit cost management. The calendar shift contributed to profitability growth by an estimated $25 million. The effect of currency translation increased Operating Income by approximately $5 million.

 

Operating Income

 

Adjusted Operating Income (AOI)

 

Q2 ’26

Q2 ’25

Change (%)

 

Q2 ’26

Q2 ’25

Change (%)

Constant Currency Change (%)

FSS United States

$193M

$152M

27%

 

$223M

$176M

27%

27%

FSS International

61

52

19%

 

69

58

19%

12%

Corporate

(34)

(29)

(18)%

 

(34)

(29)

(18)%

(18)%

Total Company

$220M

$174M

26%

 

$258M

$205M

26%

24%

May not total due to rounding

  • FSS United States increased from accelerated revenue levels, enhanced technology driving additional productivity gains, supply chain efficiencies, and effective above-unit cost management. The calendar shift favorably affected Operating Income and AOI growth by an estimated 16% and 13%, respectively.

  • FSS International grew due to higher base business and net new business along with strengthened supply chain economics, which more than offset some in-country investments during the quarter to support significant growth. Operating Income on a GAAP basis included the favorable effect of currency translation.

  • Corporate expenses experienced higher share-based compensation.

CASH FLOW AND CAPITAL STRUCTURE

Aramark reported a higher cash inflow in the second quarter compared to the prior year period, associated with stronger earnings and favorable working capital. Net cash provided by operating activities in the quarter increased 56% to $400 million, and Free Cash Flow grew 116% to $305 million.

In the second quarter, the Company proactively repaid approximately $55 million of Term Loan B due June 2030 and repurchased approximately $25 million of its common stock. Aramark has repurchased more than 5 million of its shares for an aggregate purchase price of approximately $194 million since the inception of the Company’s share repurchase program.

Aramark’s capital allocation priorities remain unchanged: invest in the business to drive and propel growth; repay debt on an ongoing basis, with leverage expected to be under 3.0x by the end of fiscal 2026; increase the dividend annually; and utilize excess cash generation to opportunistically repurchase Aramark stock.

At quarter-end, the Company had more than $1.4 billion in cash availability.

DIVIDEND DECLARATION

Aramark’s Board of Directors approved a quarterly dividend of $0.12 per share of common stock, as announced on May 6, 2026. The dividend will be payable on June 3, 2026, to stockholders of record at the close of business on May 20, 2026.

BUSINESS UPDATE

In the second quarter, Aramark delivered significant year-over-year growth in both the top and bottom line, reflecting continued momentum across the organization. The business trends remain strong heading into the second half of the fiscal year, including 1) a client retention rate exceeding 98% across the Company; 2) sustained revenue growth in FSS United States and FSS International from broad-based net new business and ongoing base business expansion; 3) new client wins that have already reached a record $1 billion; and 4) Aramark’s entry into the hyperscale AI data center market.

The Company recently launched Aramark Nexus, a new platform delivering integrated hospitality and workforce support services for the hyperscale AI data center market and other large-scale, complex, and often remote operating environments. Aramark is uniquely positioned to deliver on these integrated set of capabilities, supported by proven expertise in operating remote environments and an established competitive advantage. Aramark expects this new suite of services to generate margins above the Company average and achieve attractive investment returns. The Company believes there is substantial growth potential in this area of the business, in addition to Aramark’s broader portfolio.

OUTLOOK

The Company provides its expectations for organic revenue growth, Adjusted Operating Income growth (constant currency), Adjusted Earnings per Share growth (constant currency), and Net Debt to Covenant Adjusted EBITDA (“Leverage Ratio”) on a non-GAAP basis, and does not provide a reconciliation of such forward-looking non-GAAP measures to GAAP due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliations, including adjustments that could be made for the effect of currency translation. The fiscal 2026 outlook reflects management’s current assumptions regarding numerous evolving factors that are difficult to accurately predict, including those discussed in the Risk Factors set forth in the Company’s filings with the United States Securities and Exchange Commission.

Based on Aramark’s strong performance in the first half of the fiscal year, the Company updated its Fiscal 2026 Outlook for Organic Revenue growth and reaffirmed expectations for AOI, Adjusted EPS, and Leverage Ratio.

Aramark continues to expect accelerated AOI and margin expansion this fiscal year, consistent with the Company’s expectations, capitalizing on its multiple operating levers while mobilizing a record level of new business openings.

Aramark’s newly awarded multi-year agreement with a top global hyperscaler is underway and service set to begin this fiscal year. This new business is not currently reflected in the Company’s Fiscal 2026 Outlook with updates to be provided as the client engagement launches, grows, and scales.

Aramark currently anticipates its full-year performance for Fiscal 2026 as follows:

 

  • Organic Revenue growth at the high end of the Company’s previously stated +7% to +9%;
  • Adjusted Operating Income growth of +12% to +17%;
  • Adjusted EPS growth of +20% to +25%; and
  • Leverage Ratio under 3x

 

Note: All percentages above are on a constant currency basis

For easier comparison purposes, Fiscal 2025 Organic Revenue is on a 52-week basis

“We enter the second half of the fiscal year with confidence in our growth trajectory and our ability to capitalize on the significant opportunities immediately ahead,” Zillmer added. “Our teams continue to deliver outstanding performance, and we remain focused on building upon this momentum and driving the business to even greater levels of success.”

CONFERENCE CALL SCHEDULED

The Company has scheduled a conference call at 8:30 a.m. ET today to discuss its earnings and outlook. This call and related materials can be heard and reviewed, either live or on a delayed basis, on the Company’s website, www.aramark.com, on the investor relations page.

About Aramark

Aramark (NYSE: ARMK) proudly serves the world’s leading educational institutions, Fortune 500 companies, world champion sports teams, prominent healthcare providers, iconic destinations and cultural attractions, and numerous municipalities in 16 countries around the world with food and facilities management. Because of our hospitality culture, our employees strive to do great things for each other, our partners, our communities, and the planet. Learn more at www.aramark.com and connect with us on LinkedIn, Facebook, X, and Instagram.

Selected Operational and Financial Metrics

Adjusted Revenue (Organic)

Adjusted Revenue (Organic) represents revenue adjusted to eliminate the impact of currency translation.

Adjusted Operating Income

Adjusted Operating Income represents operating income adjusted to eliminate the impact of amortization of acquisition-related intangible assets; severance and other charges and other items impacting comparability.

Adjusted Operating Income (Constant Currency)

Adjusted Operating Income (Constant Currency) represents Adjusted Operating Income adjusted to eliminate the impact of currency translation.

Adjusted Net Income

Adjusted Net Income represents net income attributable to Aramark stockholders adjusted to eliminate the impact of amortization of acquisition-related intangible assets; severance and other charges; the effect of debt repricing and repayments on interest expense, net, and other items impacting comparability, less the tax impact of these adjustments. The tax effect for Adjusted Net Income for our United States earnings is calculated using a blended United States federal and state tax rate. The tax effect for Adjusted Net Income in jurisdictions outside the United States is calculated at the local country tax rate.

Adjusted Net Income (Constant Currency)

Adjusted Net Income (Constant Currency) represents Adjusted Net Income adjusted to eliminate the impact of currency translation.

Adjusted EPS

Adjusted EPS represents Adjusted Net Income divided by diluted weighted average shares outstanding.

Adjusted EPS (Constant Currency)

Adjusted EPS (Constant Currency) represents Adjusted EPS adjusted to eliminate the impact of currency translation.

Covenant Adjusted EBITDA

Covenant Adjusted EBITDA represents net income attributable to Aramark stockholders adjusted for interest expense, net; provision for income taxes; depreciation and amortization and certain other items as defined in our credit agreement required in calculating covenant ratios and debt compliance. We also use Net Debt for our ratio to Covenant Adjusted EBITDA, which is calculated as total long-term borrowings less cash and cash equivalents and short-term marketable securities.

Free Cash Flow

Free Cash Flow represents net cash used in operating activities less net purchases of property and equipment and other. Management believes that the presentation of free cash flow provides useful information to investors because it represents a measure of cash flow available for distribution among all the security holders of the Company.

We use Adjusted Revenue (Organic), Adjusted Operating Income (including on a constant currency basis), Adjusted Net Income (including on a constant currency basis), Adjusted EPS (including on a constant currency basis), Covenant Adjusted EBITDA and Free Cash Flow as supplemental measures of our operating profitability and to control our cash operating costs. We believe these financial measures are useful to investors because they enable better comparisons of our historical results and allow our investors to evaluate our performance based on the same metrics that we use to evaluate our performance and trends in our results. These financial metrics are not measurements of financial performance under generally accepted accounting principles, or GAAP. Our presentation of these metrics has limitations as an analytical tool and should not be considered in isolation or as a substitute for analysis of our results as reported under GAAP. You should not consider these measures as alternatives to revenue, operating income, net income, earnings per share or net cash used in operating activities, determined in accordance with GAAP. Adjusted Revenue (Organic), Adjusted Operating Income, Adjusted Net Income, Adjusted EPS, Covenant Adjusted EBITDA and Free Cash Flow as presented by us may not be comparable to other similarly titled measures of other companies because not all companies use identical calculations.

Explanatory Notes to the Non-GAAP Schedules

Amortization of Acquisition-Related Intangible Assets – adjustments to eliminate the impact of amortization expense recognized on acquisition-related intangible assets.

Severance and Other Charges – adjustments to eliminate severance expenses in the applicable period ($5.5 million for both the second quarter and year-to-date 2026).

Gains, Losses and Settlements impacting comparability – adjustments to eliminate certain transactions that are not indicative of the Company’s ongoing operational performance, primarily for non-cash charges for the impairment of certain assets related to a business held-for-sale ($6.1 million for year-to-date 2026), multiemployer pension plan withdrawal charge ($5.6 million for year-to-date 2026), legal charges related to an antitrust review ($1.3 million for year-to-date 2026), charges related to hyperinflation in Argentina ($0.9 million gain for the second quarter of 2026, $0.4 million gain for year-to-date 2026, $0.6 million loss for the second quarter of 2025 and $1.3 million loss for year-to-date 2025) and a charge for contingent consideration liabilities related to acquisition earn outs ($11.1 million for year-to-date 2025).

Effect of Debt Repayments and Refinancings on Interest Expense, net – adjustments to eliminate expenses associated with the refinancings by the Company in the applicable period such as payment of third party costs ($0.7 million for year-to-date 2026 and $5.8 million for both the second quarter and year-to-date 2025) and non-cash charges for the write-off of unamortized debt issuance costs and discounts ($0.4 million for year-to-date 2026 and $2.5 million for both the second quarter and year-to-date 2025).

Tax Impact of Adjustments to Adjusted Net Income – adjustments to eliminate the net tax impact of the adjustments to Adjusted Net Income calculated based on a blended United States federal and state tax rate for United States adjustments and the local country tax rate for adjustments in jurisdictions outside the United States. The adjustments also reverse the valuation allowance recorded based on the Company’s ability to utilize foreign tax credits ($3.4 million for year-to-date 2026). Additionally, the adjustments reverse the release of a valuation allowance recorded at a foreign subsidiary ($8.6 million benefit for both the second quarter and year-to-date 2025) and eliminates the impact of the state tax treatment related to the sale of a minority interest ($4.4 million charge for both the second quarter and year-to-date 2025) and the tax related impact of the Company’s spin-off of the Uniform segment, including non-deductible transaction costs ($3.6 million charge for both the second quarter and year-to-date 2025).

Effect of Currency Translation – adjustments to eliminate the impact that fluctuations in currency translation rates had on the comparative results by presenting the periods on a constant currency basis. Assumes constant foreign currency exchange rates based on the rates in effect for the prior year period being used in translation for the comparable current year period.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements reflect our current expectations as to future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. These statements include, but are not limited to, statements under the heading “Business Update,” “Outlook,” and those related to our expectations regarding the performance of our business, our financial results, our operations, our liquidity and capital resources, the conditions in our industry and our growth strategy. In some cases, forward-looking statements can be identified by words such as “outlook,” “aim,” “anticipate,” “have confidence,” “estimate,” “expect,” “will be,” “will continue,” “will likely result,” “project,” “intend,” “plan,” “believe,” “see,” “look to” and other words and terms of similar meaning or the negative versions of such words. These forward-looking statements are subject to risks and uncertainties that may change at any time, and actual results or outcomes may differ materially from those that we expected.

Some of the factors that we believe could affect or continue to affect our results include without limitation: unfavorable economic conditions; natural disasters, global calamities, climate change, pandemics, energy shortages, sports strikes and other adverse incidents; geopolitical events including the conflict in the Middle East, global supply chain disruptions, inflation, volatility and disruption of global financial markets; the impact of the United States’ and other countries’ trade policies including the implementation of tariffs; the failure to retain current clients, renew existing client contracts and obtain new client contracts; a determination by clients to reduce their outsourcing or use of preferred vendors; competition in our industries; increased operating costs and obstacles to cost recovery due to the pricing and cancellation terms of our food and support services contracts; currency risks and other risks associated with international operations, including compliance with a broad range of laws and regulations, including the United States Foreign Corrupt Practices Act; risks associated with suppliers from whom our products are sourced; disruptions to our relationship with our distribution partners; the contract intensive nature of our business, which may lead to client disputes; the inability to hire and retain key or sufficiently qualified personnel or increases in labor costs; our expansion strategy and our ability to successfully integrate the businesses we acquire and costs and timing related thereto; continued or further unionization of our workforce; liability resulting from our participation in multiemployer defined benefit pension plans; laws and governmental regulations including those relating to food and beverages, the environment, wage and hour and government contracting; liability associated with noncompliance with applicable law or other governmental regulations; new interpretations of or changes in the enforcement of the government regulatory framework; increases or changes in income tax rates or tax-related laws; potential liabilities, increased costs, reputational harm, and other adverse effects based on our commitments and stakeholder expectations relating to environmental, social and governance considerations; the failure to maintain food safety throughout our supply chain, food-borne illness concerns and claims of illness or injury; a cybersecurity incident or other disruptions in the availability of our computer systems or privacy breaches; the use of artificial intelligence technologies within our business processes; our leverage; variable rate indebtedness that subjects us to interest rate risk; the inability to generate sufficient cash to service all of our indebtedness; debt agreements that limit our flexibility in operating our business; risks associated with the completed spin-off of Aramark Uniform and Career Apparel (“Uniform”) as an independent publicly traded company to our stockholders; and other factors set forth under the headings “Part I, Item 1A Risk Factors,” “Part I, Item 3 Legal Proceedings” and “Part II, Item 7 Management’s Discussion and Analysis of Financial Condition and Results of Operations” and other sections of our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the “SEC”) on November 25, 2025 as such factors may be updated from time to time in our other periodic filings with the SEC, which are accessible on the SEC’s website at www.sec.gov and which may be obtained by contacting Aramark’s investor relations department via its website at www.aramark.com. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included herein and in our other filings with the SEC. As a result of these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements included herein or that may be made elsewhere from time to time by, or on behalf of, us. Forward-looking statements speak only as of the date made. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments, changes in our expectations, or otherwise, except as required by law.

ARAMARK AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

(In Thousands, Except Per Share Amounts)

 

 

 

Three Months Ended

 

 

April 3, 2026

 

March 28, 2025

Revenue

 

$

4,907,342

 

$

4,279,298

Costs and Expenses:

 

 

 

 

Cost of services provided (exclusive of depreciation and amortization)

 

 

4,480,948

 

 

3,919,653

Depreciation and amortization

 

 

132,160

 

 

117,059

Selling and general corporate expenses

 

 

74,485

 

 

68,411

Total costs and expenses

 

 

4,687,593

 

 

4,105,123

Operating income

 

 

219,749

 

 

174,175

Interest Expense, net

 

 

82,241

 

 

89,704

Income Before Income Taxes

 

 

137,508

 

 

84,471

Provision for Income Taxes

 

 

35,368

 

 

22,498

Net income

 

 

102,140

 

 

61,973

Less: Net income attributable to noncontrolling interests

 

 

190

 

 

119

Net income attributable to Aramark stockholders

 

$

101,950

 

$

61,854

 

 

 

 

 

Earnings per share attributable to Aramark stockholders:

 

 

 

 

Basic

 

$

0.39

 

$

0.23

Diluted

 

$

0.38

 

$

0.23

Weighted Average Shares Outstanding:

 

 

 

 

Basic

 

 

263,160

 

 

264,811

Diluted

 

 

266,390

 

 

267,420

 

 

 

 

 

ARAMARK AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

(In Thousands, Except Per Share Amounts)

 

 

 

Six Months Ended

 

 

April 3, 2026

 

March 28, 2025

Revenue

 

$

9,738,891

 

$

8,831,384

Costs and Expenses:

 

 

 

 

Cost of services provided (exclusive of depreciation and amortization)

 

 

8,896,321

 

 

8,070,885

Depreciation and amortization

 

 

258,114

 

 

230,263

Selling and general corporate expenses

 

 

147,158

 

 

138,797

Total costs and expenses

 

 

9,301,593

 

 

8,439,945

Operating income

 

 

437,298

 

 

391,439

Interest Expense, net

 

 

164,160

 

 

165,508

Income Before Income Taxes

 

 

273,138

 

 

225,931

Provision for Income Taxes

 

 

74,497

 

 

58,255

Net income

 

 

198,641

 

 

167,676

Less: Net income attributable to noncontrolling interests

 

 

530

 

 

203

Net income attributable to Aramark stockholders

 

$

198,111

 

$

167,473

 

 

 

 

 

Earnings per share attributable to Aramark stockholders:

 

 

 

 

Basic

 

$

0.75

 

$

0.63

Diluted

 

$

0.74

 

$

0.62

Weighted Average Shares Outstanding:

 

 

 

 

Basic

 

 

263,144

 

 

264,846

Diluted

 

 

266,382

 

 

268,076

 

 

 

 

 

ARAMARK AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In Thousands)

 

 

 

 

 

 

 

April 3, 2026

 

October 3, 2025

Assets

 

 

 

 

 

 

 

 

 

Current Assets:

 

 

 

 

Cash and cash equivalents

 

$

475,722

 

$

639,095

Receivables

 

 

2,475,099

 

 

2,210,388

Inventories

 

 

453,325

 

 

418,766

Prepayments and other current assets

 

 

341,915

 

 

254,642

Total current assets

 

 

3,746,061

 

 

3,522,891

Property and Equipment, net

 

 

1,786,495

 

 

1,734,489

Goodwill

 

 

4,980,956

 

 

4,874,670

Other Intangible Assets

 

 

1,907,892

 

 

1,874,067

Operating Lease Right-of-use Assets

 

 

825,305

 

 

701,839

Other Assets

 

 

593,941

 

 

596,673

 

 

$

13,840,650

 

$

13,304,629

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

Current maturities of long-term borrowings

 

$

33,853

 

$

31,543

Current operating lease liabilities

 

 

65,314

 

 

60,744

Accounts payable

 

 

1,246,368

 

 

1,522,747

Accrued expenses and other current liabilities

 

 

1,744,183

 

 

1,931,688

Total current liabilities

 

 

3,089,718

 

 

3,546,722

Long-Term Borrowings

 

 

6,056,336

 

 

5,374,394

Noncurrent Operating Lease Liabilities

 

 

266,806

 

 

255,305

Deferred Income Taxes and Other Noncurrent Liabilities

 

 

1,085,590

 

 

966,019

Redeemable Noncontrolling Interests

 

 

61,871

 

 

14,130

Total Stockholders’ Equity

 

 

3,280,329

 

 

3,148,059

 

 

$

13,840,650

 

$

13,304,629

 

 

 

 

 

ARAMARK AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In Thousands)

 

 

 

Six Months Ended

 

April 3, 2026

 

March 28, 2025

Cash flows from operating activities:

 

 

 

Net income

$

198,641

 

 

$

167,676

 

Adjustments to reconcile Net income to Net cash used in operating activities:

 

 

 

Depreciation and amortization

 

258,114

 

 

 

230,263

 

Asset write-downs

 

6,058

 

 

 

 

Increase in contingent consideration liability

 

 

 

 

11,127

 

Deferred income taxes

 

37,430

 

 

 

2,931

 

Share-based compensation expense

 

34,793

 

 

 

30,296

 

Changes in operating assets and liabilities

 

(839,069

)

 

 

(724,340

)

Payments made to clients on contracts

 

(151,368

)

 

 

(86,850

)

Other operating activities

 

73,453

 

 

 

37,693

 

Net cash used in operating activities

 

(381,948

)

 

 

(331,204

)

Cash flows from investing activities:

 

 

 

Net purchases of property and equipment and other

 

(214,878

)

 

 

(232,486

)

Acquisitions, divestitures and other investing activities

 

(101,637

)

 

 

(249,984

)

Net cash used in investing activities

 

(316,515

)

 

 

(482,470

)

Cash flows from financing activities:

 

 

 

Net proceeds/payments of long-term borrowings

 

(83,443

)

 

 

414,590

 

Net change in Revolving Credit Facility

 

140,366

 

 

 

275,882

 

Net change in funding under the Receivables Facility

 

625,000

 

 

 

586,000

 

Payments of dividends

 

(63,068

)

 

 

(55,683

)

Proceeds from issuance of common stock

 

19,288

 

 

 

16,379

 

Repurchase of common stock

 

(66,322

)

 

 

(109,283

)

Payments for contingent considerations

 

(33,697

)

 

 

(10,505

)

Other financing activities

 

(5,677

)

 

 

(50,816

)

Net cash provided by financing activities

 

532,447

 

 

 

1,066,564

 

Effect of foreign exchange rates on cash and cash equivalents and restricted cash

 

(335

)

 

 

(11,497

)

(Decrease) Increase in cash and cash equivalents and restricted cash

 

(166,351

)

 

 

241,393

 

Cash and cash equivalents and restricted cash, beginning of period

 

707,144

 

 

 

732,613

 

Cash and cash equivalents and restricted cash, end of period

$

540,793

 

 

$

974,006

 

   

Balance Sheet classification

April 3, 2026

 

March 28, 2025

Cash and cash equivalents

$

475,722

 

$

920,455

Restricted cash in Prepayments and other current assets

65,071

 

53,551

Total cash and cash equivalents and restricted cash

$

540,793

 

$

974,006

ARAMARK AND SUBSIDIARIES

RECONCILIATION OF NON-GAAP MEASURES

ADJUSTED CONSOLIDATED OPERATING INCOME MARGIN

(Unaudited)

(In thousands)

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

April 3, 2026

 

 

FSS United States

 

FSS International

 

Corporate

 

Aramark and Subsidiaries

Revenue (as reported)

 

$

3,430,268

 

 

$

1,477,074

 

 

 

 

$

4,907,342

 

Operating Income (as reported)

 

$

192,620

 

 

$

61,408

 

 

$

(34,279

)

 

$

219,749

 

Operating Income Margin (as reported)

 

 

5.6

%

 

 

4.2

%

 

 

 

 

4.5

%

 

 

 

 

 

 

 

 

 

Revenue (as reported)

 

$

3,430,268

 

 

$

1,477,074

 

 

 

 

$

4,907,342

 

Effect of Currency Translation

 

 

(1,963

)

 

 

(99,098

)

 

 

 

 

(101,061

)

Adjusted Revenue (Organic)

 

$

3,428,305

 

 

$

1,377,976

 

 

 

 

$

4,806,281

 

Revenue Growth (as reported)

 

 

12.2

%

 

 

20.8

%

 

 

 

 

14.7

%

Adjusted Revenue Growth (Organic)

 

 

12.2

%

 

 

12.7

%

 

 

 

 

12.3

%

 

 

 

 

 

 

 

 

 

Operating Income (as reported)

 

$

192,620

 

 

$

61,408

 

 

$

(34,279

)

 

$

219,749

 

Amortization of Acquisition-Related Intangible Assets

 

 

25,114

 

 

 

8,244

 

 

 

 

 

 

33,358

 

Severance and Other Charges

 

 

5,512

 

 

 

 

 

 

 

 

 

5,512

 

Gains, Losses and Settlements impacting comparability

 

 

 

 

 

(916

)

 

 

 

 

 

(916

)

Adjusted Operating Income

 

$

223,246

 

 

$

68,736

 

 

$

(34,279

)

 

$

257,703

 

Effect of Currency Translation

 

 

(536

)

 

 

(3,978

)

 

 

 

 

 

(4,514

)

Adjusted Operating Income (Constant Currency)

 

$

222,710

 

 

$

64,758

 

 

$

(34,279

)

 

$

253,189

 

 

 

 

 

 

 

 

 

 

Operating Income Growth (as reported)

 

 

27.0

%

 

 

19.1

%

 

 

(17.9

)%

 

 

26.2

%

Adjusted Operating Income Growth

 

 

26.9

%

 

 

18.5

%

 

 

(17.9

)%

 

 

25.8

%

Adjusted Operating Income Growth (Constant Currency)

 

 

26.6

%

 

 

11.6

%

 

 

(17.9

)%

 

 

23.6

%

Adjusted Operating Income Margin

 

 

6.5

%

 

 

4.7

%

 

 

 

 

5.3

%

Adjusted Operating Income Margin (Constant Currency)

 

 

6.5

%

 

 

4.7

%

 

 

 

 

5.3

%

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

March 28, 2025

 

 

FSS United States

 

FSS International

 

Corporate

 

Aramark and Subsidiaries

Revenue (as reported)

 

$

3,056,338

 

 

$

1,222,960

 

 

 

 

$

4,279,298

 

 

 

 

 

 

 

 

 

 

Operating Income (as reported)

 

$

151,686

 

 

$

51,553

 

 

$

(29,063

)

 

$

174,176

 

Amortization of Acquisition-Related Intangible Assets

 

 

24,195

 

 

 

5,827

 

 

 

 

 

 

30,022

 

Gains, Losses and Settlements impacting comparability

 

 

 

 

 

622

 

 

 

 

 

 

622

 

Adjusted Operating Income

 

$

175,881

 

 

$

58,002

 

 

$

(29,063

)

 

$

204,820

 

 

 

 

 

 

 

 

 

 

Operating Income Margin (as reported)

 

 

5.0

%

 

 

4.2

%

 

 

 

 

4.1

%

Adjusted Operating Income Margin

 

 

5.8

%

 

 

4.7

%

 

 

 

 

4.8

%

 

 

 

 

 

 

 

 

 

ARAMARK AND SUBSIDIARIES

RECONCILIATION OF NON-GAAP MEASURES

ADJUSTED CONSOLIDATED OPERATING INCOME MARGIN

(Unaudited)

(In thousands)

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended

 

 

April 3, 2026

 

 

FSS United States

 

FSS International

 

Corporate

 

Aramark and Subsidiaries

Revenue (as reported)

 

$

6,792,374

 

 

$

2,946,517

 

 

$

 

 

$

9,738,891

 

Operating Income (as reported)

 

$

381,368

 

 

$

121,198

 

 

$

(65,268

)

 

$

437,298

 

Operating Income Margin (as reported)

 

 

5.6

%

 

 

4.1

%

 

 

 

 

4.5

%

 

 

 

 

 

 

 

 

 

Revenue (as reported)

 

$

6,792,374

 

 

$

2,946,517

 

 

 

 

$

9,738,891

 

Effect of Currency Translation

 

 

(2,035

)

 

 

(150,401

)

 

 

 

 

(152,436

)

Adjusted Revenue (Organic)

 

$

6,790,339

 

 

$

2,796,116

 

 

 

 

$

9,586,455

 

Revenue Growth (as reported)

 

 

6.8

%

 

 

19.1

%

 

 

 

 

10.3

%

Adjusted Revenue Growth (Organic)

 

 

6.8

%

 

 

13.0

%

 

 

 

 

8.5

%

 

 

 

 

 

 

 

 

 

Operating Income (as reported)

 

$

381,368

 

 

$

121,198

 

 

$

(65,268

)

 

$

437,298

 

Amortization of Acquisition-Related Intangible Assets

 

 

50,276

 

 

 

15,083

 

 

 

 

 

 

65,359

 

Severance and Other Charges

 

 

5,512

 

 

 

 

 

 

 

 

 

5,512

 

Gains, Losses and Settlements impacting comparability

 

 

11,608

 

 

 

915

 

 

 

 

 

 

12,523

 

Adjusted Operating Income

 

$

448,764

 

 

$

137,196

 

 

$

(65,268

)

 

$

520,692

 

Effect of Currency Translation

 

 

(533

)

 

 

(6,106

)

 

 

 

 

 

(6,639

)

Adjusted Operating Income (Constant Currency)

 

$

448,231

 

 

$

131,090

 

 

$

(65,268

)

 

$

514,053

 

 

 

 

 

 

 

 

 

 

Operating Income Growth (as reported)

 

 

10.4

%

 

 

15.2

%

 

 

(10.2

)%

 

 

11.7

%

Adjusted Operating Income Growth

 

 

10.9

%

 

 

17.3

%

 

 

(10.2

)%

 

 

12.6

%

Adjusted Operating Income Growth (Constant Currency)

 

 

10.8

%

 

 

12.0

%

 

 

(10.2

)%

 

 

11.2

%

Adjusted Operating Income Margin

 

 

6.6

%

 

 

4.7

%

 

 

 

 

5.3

%

Adjusted Operating Income Margin (Constant Currency)

 

 

6.6

%

 

 

4.7

%

 

 

 

 

5.4

%

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended

 

 

March 28, 2025

 

 

FSS United States

 

FSS International

 

Corporate

 

Aramark and Subsidiaries

Revenue (as reported)

 

$

6,357,354

 

 

$

2,474,030

 

 

 

 

$

8,831,384

 

 

 

 

 

 

 

 

 

 

Operating Income (as reported)

 

$

345,404

 

 

$

105,238

 

 

$

(59,203

)

 

$

391,439

 

Amortization of Acquisition-Related Intangible Assets

 

 

48,054

 

 

 

10,452

 

 

 

 

 

 

58,506

 

Gains, Losses and Settlements impacting comparability

 

 

11,127

 

 

 

1,315

 

 

 

 

 

 

12,442

 

Adjusted Operating Income

 

$

404,585

 

 

$

117,005

 

 

$

(59,203

)

 

$

462,387

 

 

 

 

 

 

 

 

 

 

Operating Income Margin (as reported)

 

 

5.4

%

 

 

4.3

%

 

 

 

 

4.4

%

Adjusted Operating Income Margin

 

 

6.4

%

 

 

4.7

%

 

 

 

 

5.2

%

 

 

 

 

 

 

 

 

 

ARAMARK AND SUBSIDIARIES

RECONCILIATION OF NON-GAAP MEASURES

ADJUSTED NET INCOME & ADJUSTED EARNINGS PER SHARE

(Unaudited)

(In thousands, except per share amounts)

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

April 3,

2026

 

March 28,

2025

 

April 3,

2026

 

March 28,

2025

Net Income Attributable to Aramark Stockholders (as reported)

 

$

101,950

 

 

$

61,854

 

 

$

198,111

 

 

$

167,473

 

 

Adjustment:

 

 

 

 

 

 

 

 

 

Amortization of Acquisition-Related Intangible Assets

 

 

33,358

 

 

 

30,022

 

 

 

65,359

 

 

 

58,506

 

 

Severance and Other Charges

 

 

5,512

 

 

 

 

 

 

5,512

 

 

 

 

 

Gains, Losses and Settlements impacting comparability

 

 

(916

)

 

 

622

 

 

 

12,523

 

 

 

12,442

 

 

Effect of Debt Repricing and Repayments on Interest Expense, net

 

 

 

 

 

8,326

 

 

 

1,121

 

 

 

8,326

 

 

Tax Impact of Adjustments to Adjusted Net Income

 

 

(9,058

)

 

 

(9,030

)

 

 

(16,226

)

 

 

(18,019

)

Adjusted Net Income

 

$

130,846

 

 

$

91,794

 

 

$

266,400

 

 

$

228,728

 

 

Effect of Currency Translation, net of Tax

 

 

(2,980

)

 

 

 

 

 

(3,851

)

 

 

 

Adjusted Net Income (Constant Currency)

 

$

127,866

 

 

$

91,794

 

 

$

262,549

 

 

$

228,728

 

 

 

 

 

 

 

 

 

 

 

Earnings Per Share (as reported)

 

 

 

 

 

 

 

 

 

Net Income Attributable to Aramark Stockholders (as reported)

 

$

101,950

 

 

$

61,854

 

 

$

198,111

 

 

$

167,473

 

 

Diluted Weighted Average Shares Outstanding

 

 

266,390

 

 

 

267,420

 

 

 

266,382

 

 

 

268,076

 

 

 

 

$

0.38

 

 

$

0.23

 

 

$

0.74

 

 

$

0.62

 

 

Earnings Per Share Growth (as reported) %

 

 

65.5

%

 

 

 

 

19.0

%

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted Earnings Per Share

 

 

 

 

 

 

 

 

 

Adjusted Net Income

 

$

130,846

 

 

$

91,794

 

 

$

266,400

 

 

$

228,728

 

 

Diluted Weighted Average Shares Outstanding

 

 

266,390

 

 

 

267,420

 

 

 

266,382

 

 

 

268,076

 

 

 

 

$

0.49

 

 

$

0.34

 

 

$

1.00

 

 

$

0.85

 

 

Adjusted Earnings Per Share Growth %

 

 

43.1

%

 

 

 

 

17.2

%

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted Earnings Per Share (Constant Currency)

 

 

 

 

 

 

 

 

 

Adjusted Net Income (Constant Currency)

 

$

127,866

 

 

$

91,794

 

 

$

262,549

 

 

$

228,728

 

 

Diluted Weighted Average Shares Outstanding

 

 

266,390

 

 

 

267,420

 

 

 

266,382

 

 

 

268,076

 

 

 

 

$

0.48

 

 

$

0.34

 

 

$

0.99

 

 

$

0.85

 

 

Adjusted Earnings Per Share Growth (Constant Currency) %

 

 

39.8

%

 

 

 

 

15.5

%

 

 

ARAMARK AND SUBSIDIARIES

RECONCILIATION OF NON-GAAP MEASURES

NET DEBT TO COVENANT ADJUSTED EBITDA

(Unaudited)

(In thousands)

 

 

 

 

 

 

 

 

 

Twelve Months Ended

 

 

 

April 3, 2026

 

March 28, 2025

Net Income Attributable to Aramark Stockholders (as reported)

 

$

357,032

 

$

348,010

 

 

Interest Expense, net

 

 

340,577

 

 

331,285

 

 

Provision for Income Taxes

 

 

119,828

 

 

117,649

 

 

Depreciation and Amortization

 

 

504,196

 

 

451,148

 

 

Share-based compensation expense(1)

 

 

62,695

 

 

63,062

 

 

Unusual or non-recurring losses and (gains)(2)

 

 

25,523

 

 

(25,071

)

 

Pro forma EBITDA for certain transactions(3)

 

 

36,604

 

 

28,502

 

 

Other(4)(5)

 

 

127,504

 

 

95,335

 

Covenant Adjusted EBITDA

 

$

1,573,959

 

$

1,409,920

 

 

 

 

 

 

Net Debt to Covenant Adjusted EBITDA

 

 

 

 

 

Total Long-Term Borrowings

 

$

6,090,189

 

$

6,532,881

 

 

Less: Cash and cash equivalents and short-term marketable securities(6)

 

 

475,722

 

 

963,721

 

 

Net Debt

 

$

5,614,467

 

$

5,569,160

 

 

Covenant Adjusted EBITDA

 

$

1,573,959

 

$

1,409,920

 

 

Net Debt/Covenant Adjusted EBITDA

 

 

3.6

 

 

3.9

 

 

 

 

 

 

(1) Represents share-based compensation expense of equity awards resulting from the application of accounting for stock options, restricted stock units, performance stock units and deferred stock unit awards.

(2) The twelve months ended April 3, 2026 represents a fiscal 2025 non-cash charge for the impairment on an equity investment ($19.5 million) and a fiscal 2026 non-cash charge for the impairment of certain assets related to a business held-for-sale ($6.1 million). The twelve months ended March 28, 2025 represents a fiscal 2024 gain from the sale of the Company’s remaining equity investment in the San Antonio Spurs NBA franchise ($25.1 million).

(3) Represents the annualizing of net EBITDA from certain acquisitions made during the period and, for purposes of the Credit Agreement, the net benefit from cost savings initiatives ($16.3 million for the twelve months ended April 3, 2026).

(4) “Other” for the twelve months ended April 3, 2026 includes adjustments to remove the impact attributable to the adoption of certain accounting standards that are made to the calculation in accordance with the Credit Agreement and indentures ($56.4 million), severance charges ($41.9 million), non-cash charges for the impairments of assets ($8.9 million), multiemployer pension plan withdrawal charge ($5.6 million), merger and integration charges ($4.9 million), the impact of hyperinflation in Argentina ($4.0 million), legal charges related to an antitrust review ($3.8 million) and other miscellaneous expenses.

(5) “Other” for the twelve months ended March 28, 2025 includes adjustments to remove the impact attributable to the adoption of certain accounting standards that are made to the calculation in accordance with the Credit Agreement and indentures ($52.8 million), non-cash adjustments to inventory based on expected usage ($18.2 million), charges related to a ruling on a foreign tax matter ($6.8 million), severance charges ($6.7 million), non-cash charges related to the impairment of a trade name ($3.3 million), contingent consideration expense related to acquisition earn outs, net of reversals ($2.4 million), the impact of hyperinflation in Argentina ($1.9 million) and other miscellaneous expenses.

(6) Short-term marketable securities represent held-to-maturity debt securities with original maturities greater than three months, which are maturing within one year and will convert back to cash. Short-term marketable securities are included in “Prepayments and other current assets” on the Condensed Consolidated Balance Sheets.

ARAMARK AND SUBSIDIARIES

RECONCILIATION OF NON-GAAP MEASURES

FREE CASH FLOW

(Unaudited)

(In thousands)

 

 

 

 

 

 

 

Six Months Ended

 

Three Months Ended

 

Three Months Ended

 

April 3, 2026

 

January 2, 2026

 

April 3, 2026

Net cash (used in) provided by operating activities

$

(381,948

)

 

$

(782,200

)

 

$

400,252

 

 

 

 

 

 

 

Net purchases of property and equipment and other

 

(214,878

)

 

 

(120,033

)

 

 

(94,845

)

 

 

 

 

 

 

Free Cash Flow

$

(596,826

)

 

$

(902,233

)

 

$

305,407

 

 

 

 

 

 

 

 

Six Months Ended

 

Three Months Ended

 

Three Months Ended

 

March 28, 2025

 

December 27, 2024

 

March 28, 2025

Net cash (used in) provided by operating activities

$

(331,204

)

 

$

(587,152

)

 

$

255,948

 

 

 

 

 

 

 

Net purchases of property and equipment and other

 

(232,486

)

 

 

(117,788

)

 

 

(114,698

)

 

 

 

 

 

 

Free Cash Flow

$

(563,690

)

 

$

(704,940

)

 

$

141,250

 

 

 

 

 

 

 

 

Six Months Ended

 

Three Months Ended

 

Three Months Ended

 

Change

 

Change

 

Change

Net cash (used in) provided by operating activities

$

(50,744

)

 

$

(195,048

)

 

$

144,304

 

 

 

 

 

 

 

Net purchases of property and equipment and other

 

17,608

 

 

 

(2,245

)

 

 

19,853

 

 

 

 

 

 

 

Free Cash Flow

$

(33,136

)

 

$

(197,293

)

 

$

164,157

 

 

Inquiries:

Felise Glantz Kissell

(215) 409-7287

[email protected]

Gene Cleary

(215) 409-7945

[email protected]

KEYWORDS: Pennsylvania United States North America

INDUSTRY KEYWORDS: Technology Licensing (Sports) Construction & Property Sports General Sports Software Food/Beverage Other Construction & Property Retail Artificial Intelligence

MEDIA:

Logo
Logo

Ouster Brings REV8 Native Color Lidar to the NVIDIA DRIVE Hyperion Platform for Autonomous Vehicle Development

Ouster Brings REV8 Native Color Lidar to the NVIDIA DRIVE Hyperion Platform for Autonomous Vehicle Development

SAN FRANCISCO–(BUSINESS WIRE)–Ouster, Inc. (Nasdaq: OUST) (“Ouster” or the “Company”), a leader in sensing and perception for Physical AI, announced today its new Rev8 OS family of digital lidar sensors are qualified to run on the NVIDIA DRIVE Hyperion platform for accelerating development and deployment of level 4 autonomous vehicles.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260512349586/en/

NVIDIA HQ captured by an Ouster Rev8 native color lidar in Santa Clara, CA.

NVIDIA HQ captured by an Ouster Rev8 native color lidar in Santa Clara, CA.

Rev8 Sensor Compatibility with NVIDIA DRIVE Hyperion

As a vendor within the open NVIDIA DRIVE ecosystem, Ouster’s Rev8 OS have met the requirements of DRIVE Hyperion’s sensor qualification process. Ouster pairs hardware readiness with full-stack software compatibility, featuring optimized plugins for its entire sensor portfolio within the NVIDIA DriveWorks SDK. By bridging these layers, Ouster’s high-density point clouds can be ingested directly into NVIDIA’s hardware-accelerated software stack, providing automotive developers a streamlined path from initial development to full-scale deployment.

Longer-Range, Native Color Sensors for High-Speed Autonomy

Ouster’s new Rev8 OS sensors represent a dramatic leap in performance for autonomous transportation. Featuring the world’s first native color lidar, Rev8 provides the high-quality data necessary to both train next-generation world models and enable safer autonomous navigation at scale. Rev8 also introduced the flagship OS1 Max, a sensor purpose-built for high-speed autonomy that delivers 256 channels of high-definition sensing up to 500 meters in all directions and is capable of resolving the smallest objects at long range. The Rev8 family is auto-grade, cybersecure, and designed for functional safety.

A More Efficient Approach to Ground Truth Data Collection

Modern ADAS systems are trained with a combination of simulated and labeled data. Ouster’s Rev8 native color lidar makes this process faster and more affordable by delivering inherently fused color and depth data. This allows developers to access automated annotation pipelines that label data with higher precision and less manual effort, significantly reducing the time and cost of training autonomous systems.

Ouster’s work with NVIDIA DRIVE centers on providing the high-performance sensing required for the next generation of autonomous vehicles,” said Ouster CEO Angus Pacala. “With Rev8 compatibility on the NVIDIA DRIVE Hyperion platform, automotive customers around the world can benefit from superior range and resolution, along with the world’s first native color lidar, to enhance safety and performance in the real world.”

Learn more about the new Rev8 OS family here or download Ouster’s NVIDIA DriveWorks plugins here.

About Ouster

Ouster (Nasdaq: OUST) is a leader in sensing and perception for Physical AI across industrial, robotics, automotive, and smart infrastructure. With a unified platform of high-performance digital lidar, cameras, AI compute, sensor fusion and perception software, and AI models, Ouster delivers solutions that improve quality of life in the physical world. Headquartered in San Francisco, CA, Ouster has a global presence serving thousands of customers with offices in the Americas, Europe, and Asia-Pacific. For more information about our products, visit www.ouster.com, contact our sales team, or connect with us on X or LinkedIn.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements are based upon current plans, estimates and expectations of management that are subject to various risks and uncertainties that could cause actual results to differ materially from such statements. The inclusion of forward-looking statements should not be regarded as a representation that such plans, estimates and expectations will be achieved. Words such as “expect,” “will”, “may,” “anticipate,” “intend,” “allow,” “developing,” “should,” “can,” “could,” “possible,” “potential,” “pursue,” “demonstrate,” and the negative of these terms and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. All statements, other than historical facts, including statements regarding the capabilities and benefits of Ouster’s digital lidar, the demand for and the scalability of Ouster’s product offerings, Ouster’s strategy and competitive position, anticipated performance, benefits to and expectations around customer adoption and application of our products, all constitute forward-looking statements. All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that we expected, including, but not limited to, Ouster’s ability to anticipate market demand for its products and offerings; product quality and liability risks; the possibility of cancellation or postponement of contracts or unsuccessful implementations; risks related to the adoption of Ouster’s products, inaccurate forecasts of market growth and customer demand; Ouster’s ability to respond to evolving regulations and standards; and other important risk factors discussed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, and as may be further updated from time to time in the Company’s Quarterly Reports on Form 10-Q and other filings with the SEC. Readers are urged to consider these factors carefully and in the totality of the circumstances when evaluating these forward-looking statements, and not to place undue reliance on any of them. Any such forward-looking statements represent management’s reasonable estimates and beliefs as of the date of this press release. While Ouster may elect to update such forward-looking statements at some point in the future, it disclaims any obligation to do so, other than as may be required by law, even if subsequent events cause its views to change. 

For Investors

[email protected]

For Media

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Software Vehicle Technology Hardware Robotics Data Management Technology Autonomous Driving/Vehicles Automotive Artificial Intelligence Audio/Video Automotive Manufacturing Manufacturing

MEDIA:

Photo
Photo
NVIDIA HQ captured by an Ouster Rev8 native color lidar in Santa Clara, CA.
Photo
Photo
Ouster brings Rev8 native color lidar to the NVIDIA Drive Hyperion Platform for autonomous vehicle development.
Photo
Photo
NVIDIA HQ captured by an Ouster Rev8 native color lidar in Santa Clara, CA.
Logo
Logo

PSIX INVESTOR ALERT: Power Solutions International, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

PR Newswire

SAN DIEGO, May 12, 2026 /PRNewswire/ — The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Power Solutions International, Inc. (NASDAQ: PSIX) securities between May 8, 2025 and March 2, 2026, inclusive (the “Class Period”), have until May 19, 2026 to seek appointment as lead plaintiff of the Power Solutions International class action lawsuit.  Captioned Dishion v. Power Solutions International, Inc., No. 26-cv-03149 (N.D. Ill.), the Power Solutions International class action lawsuit charges Power Solutions International and certain of Power Solutions International’s top executive officers with violations of the Securities Exchange Act of 1934.

If you suffered substantial losses and wish to serve as lead plaintiff of the

Power Solutions International

class action lawsuit, please provide your information here:


https://www.rgrdlaw.com/cases-power-solutions-international-inc-class-action-lawsuit-psix.html

You can also contact attorneys

Ken Dolitsky

or

Michael Albert

of Robbins Geller by calling 800/851-7783 or via e-mail at

[email protected]

.

CASE ALLEGATIONS: Power Solutions International designs, engineers, manufactures, markets, and sells engines and power systems.

The Power Solutions International class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) Power Solutions International overstated its ability to capture sales demand for its power systems solutions, particularly within the data center market; and (ii) Power Solutions International understated the impact of its enhancements to manufacturing capacity to meet demand within the data center market, including the expected costs and the nature of the related “inefficiencies.”

The Power Solutions International class action lawsuit further alleges that on November 6, 2025, Power Solutions International released its third quarter 2025 financial results, revealing that “gross margin in the third quarter of 2025 was 23.9%, a decrease of 5.0%” year-over- year due in part to “temporary inefficiencies related to [Power Solutions International’s] accelerated production ramp-up” for “key data center product lines.”  Power Solutions International also allegedly revealed that it “anticipates … sales growth of 45%” for full year 2025, which indicated a sharp deceleration as Power Solutions International had reported year-over-year growth of 74% in the second quarter and 65% in the third quarter 2025.  On this news, the price of Power Solutions International stock fell more than 19%, according to the complaint.

Then, on March 2, 2026, Power Solutions International announced fourth quarter and full year 2025 financial results, revealing that gross margin declined 8% year-over-year due to “operating inefficiencies related to [Power Solutions International’s] accelerated production ramp-up for data center product lines.”  Power Solutions International also provided its outlook for 2026, allegedly including only “moderate margin improvement from the products serving data center markets.”  On this news, the price of Power Solutions International stock fell nearly 29%, according to the complaint.

THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired Power Solutions International securities during the Class Period to seek appointment as lead plaintiff in the Power Solutions International class action lawsuit.  A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class.  A lead plaintiff acts on behalf of all other class members in directing the Power Solutions International investor class action lawsuit.  The lead plaintiff can select a law firm of its choice to litigate the Power Solutions International shareholder class action lawsuit.  An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Power Solutions International class action lawsuit.

ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world’s leading law firms representing investors in securities fraud and shareholder rights litigation.  Our Firm ranked #1 on the most recent ISS Securities Class Action Services Top 50 Report, recovering more than $916 million for investors in 2025.  This marks our fourth #1 ranking in the past five years.  And in those five years alone, Robbins Geller recovered $8.4 billion for investors – $3.4 billion more than any other law firm.  With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs’ firms in the world, and the Firm’s attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig.  Please visit the following page for more information:


https://www.rgrdlaw.com/services-litigation-securities-fraud.html

Past results do not guarantee future outcomes. 

Services may be performed by attorneys in any of our offices. 

Contact:

          Robbins Geller Rudman & Dowd LLP

          Ken Dolitsky

          Michael Albert

          655 W. Broadway, Suite 1900, San Diego, CA 92101

          800/851-7783

          [email protected]

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/psix-investor-alert-power-solutions-international-inc-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-302768960.html

SOURCE Robbins Geller Rudman & Dowd LLP

VPG Reports Fiscal 2026 First Quarter Results; Orders Exceed $100 million and Revenue Grew Sequentially and Year-over-Year

CHESTERBROOK, Pa., May 12, 2026 (GLOBE NEWSWIRE) — Vishay Precision Group, Inc. (NYSE: VPG), a leader in precision measurement and sensing technologies, today announced its results for its fiscal 2026 first quarter ended April 4, 2026.

First Fiscal Quarter Highlights (comparisons are to the comparable period a year ago):

  • Net revenues of $84.4 million increased 17.6%
  • Gross profit margin was 39.0% as compared to 37.7%
  • Adjusted gross profit margin* was 39.0% as compared to 38.4%
  • Operating margin was 0.4% as compared to (0.1)%
  • Adjusted operating margin* was 1.9%, as compared to 1.9%
  • Diluted net loss per share of $0.02 compared to a diluted net loss per share of $0.07
  • Adjusted diluted net earnings per share* of $ 0.07 compared to $ 0.07.
  • Adjusted EBITDA* was $5.9 million with an adjusted EBITDA margin* of 7.0%

Ziv Shoshani, Chief Executive Officer of VPG, commented, “We delivered an excellent start to fiscal 2026, with revenue growing 4.7% sequentially and 17.6% year over year. Bookings of $102.1 million increased 25.5% sequentially, reaching the third-highest quarterly level in VPG’s history, driven by a 29.0% sequential bookings growth in our Sensors segment due to strong demand across semiconductor equipment, data centers, avionics, military and space, and select industrial markets. Our consolidated book-to-bill of 1.21 reflects continued momentum, as all three segments reported book-to-bill ratios well in excess of 1.0. We are also encouraged by our progress in humanoid robotics, with $1.0 million of orders booked in the first quarter and initial engineering discussions underway with a fourth humanoid developer. With our new organizational structure now in place, we are executing key initiatives to drive accelerated growth and operational excellence as we position VPG to capture long-term opportunities in growth markets.”

Mr. Shoshani added: “Profitability in the quarter reflects deliberate investments to support our new operating model and growth initiatives, which we expect to drive improved operating leverage over time. Given current bookings trends and backlog, we are positive about our business environment for 2026. We also announced a revised target model that reflects accelerated organic top-line growth, supported by our business development initiatives, disciplined commercial execution, and investments in our new organization.”

First Fiscal Quarter Financial Trends:

The Company’s first fiscal quarter 2026 net loss attributable to VPG stockholders was $(0.3) million, or $(0.02) per diluted share, compared to net loss of $(0.9) million or $(0.07) per diluted share in the first fiscal quarter of 2025.

The first fiscal quarter 2026 adjusted net earnings* were $0.9 million, or $0.07 of adjusted diluted net earnings per share*, compared to $0.9 million or $ 0.07 of adjusted diluted net earnings per share* in the first fiscal quarter of 2025.
  
Segment Performance:
The Sensors segment bookings in the first fiscal quarter of 2026 grew 29.0% sequentially, resulting in a book-to-bill of 1.36. 
The Sensors segment revenues of $33.3 million in the first fiscal quarter of 2026 increased 23.1% from $27.1 million in the first fiscal quarter of 2025. Sequentially, revenue increased 9.6% compared to $30.4 million in the fourth fiscal quarter of 2025. The year-over-year increase in revenues was primarily attributable to higher sales of precision resistors in the Test and Measurement and higher sales of strain gage sensors in the AMS and Other markets. Sequentially, the increase primarily reflected higher sales of precision resistors in the Test & Measurement and AMS markets and higher sales of strain gages in the General Industrial market.

Adjusted gross profit margin* for the Sensors segment was 34.8% for the first fiscal quarter of 2026, which increased from 30.8% in the first fiscal quarter of 2025 and increased from 28.5% in the fourth fiscal quarter of 2025. The year-over-year and sequential increases in gross profit margin were primarily due to higher volume, favorable product mix, higher manufacturing efficiencies, partially offset by unfavorable foreign currency exchange rates and higher personnel costs. 

First-quarter 2026 bookings for the Weighing Solutions segment grew 16.8% sequentially, contributing to a book-to-bill of 1.09.

The Weighing Solutions segment revenues of $30.2 million in the first fiscal quarter of 2026 increased 14.4% from $26.4 million in the first fiscal quarter of 2025.  Sequentially, revenue increased 9.0% compared to $27.7 million in the fourth fiscal quarter of 2025. The year-over-year increase in revenues was mainly attributable to higher sales in the Other markets for medical applications, and the Industrial Weighing market. Sequentially, the increase in revenues was primarily due to higher sales in our Other markets and in our Transportation market.

Gross profit margin for the Weighing Solutions segment was 34.2% for the first fiscal quarter of 2026, which decreased from adjusted gross margin of 37.8% in the first fiscal quarter of 2025 and increased from 33.0% in the fourth fiscal quarter of 2025. The year-over-year decrease in gross profit margin was primarily due to unfavorable product mix, higher manufacturing and fixed costs, partially offset by higher volume and favorable foreign currency exchange rates. The sequential increase in gross profit margin primarily reflected higher volume and favorable foreign currency  exchange rates. 

The Measurement Systems segment bookings in the first fiscal quarter of 2026 grew 32.3% sequentially, resulting in a book-to-bill of 1.15.

The Measurement Systems segment revenues of $20.8 million in the first fiscal quarter of 2026 increased 14.0% from $18.2 million in the first fiscal quarter of 2025. Sequentially, revenue decreased 7.3% compared to $22.4 million in the fourth fiscal quarter of 2025. The year-over-year increase was primarily attributable to higher revenue in the AMS market, which offset lower sales in the Steel and Transportation markets. Sequentially, the decrease in revenue was primarily due to lower sales in the Steel market which offset higher sales in the AMS market.

Gross profit margin for the Measurement Systems segment was 52.6% for the first fiscal quarter of 2026, which increased from 50.3% in the first fiscal quarter of 2025 and decreased from 52.8% in the fourth fiscal quarter of 2025. This compares with adjusted gross margin* of 50.3% in the first quarter of fiscal 2025, which reflected acquisition purchase accounting adjustments of $0.1 million. The year-over-year increase in gross profit margin was primarily due to higher volume and favorable product mix. The sequential decline in gross margin was primarily due to lower volume and wage increases, partially offset by favorable product mix.

Near-Term Outlook

“For the second fiscal quarter of 2026 at constant first fiscal quarter 2026 foreign currency exchange rates, we expect net revenues to be in the range of $85 million to $90 million,” said Mr. Shoshani.

*Use of Non-GAAP Financial Information:

Beginning in fiscal 2026, the Company revised its definition of certain non-GAAP financial measures to exclude share-based compensation expense in addition to the other items described below. This change is being made in light of the Company’s evolving compensation structure following recent organizational changes, including the hiring of senior executives and the expansion of equity-based incentive programs to attract and retain key talent.

Management believes that excluding share-based compensation expense in certain non-GAAP financial measures provides investors with additional insight into the Company’s core operating performance and enhanced understanding of business trends across reporting periods, including those in comparison to its main peer companies.

Share-based compensation expense will continue to be reflected in the Company’s GAAP financial results and will be set forth in a specific line item in the reconciliation table between GAAP and non-GAAP measures. Prior-period non-GAAP financial measures have been recast to conform to the current presentation.

The Company defines “adjusted gross profit margin” as gross profit margin before start-up costs and acquisition purchase accounting adjustments and share-based compensation expense. “Adjusted operating margin” is defined as operating margin before start-up costs, acquisition purchase accounting adjustments, restructuring costs, severance costs, share-based compensation expense and gain on sale of asset held for sale. “Adjusted net earnings” and “adjusted diluted net earnings per share” are defined as net earnings attributable to VPG stockholders before start-up costs, acquisition purchase accounting adjustments, restructuring costs and severance costs, share-based compensation expense, foreign currency exchange gains and losses, associated tax effects, and gain on sale of asset held for sale. We define “Adjusted EBITDA” as earnings before interest, taxes, depreciation, and amortization, start-up costs, acquisition purchase accounting adjustments, restructuring costs and severance costs, foreign currency exchange gains and losses, share-based compensation expense and gain on sale of asset held for sale.

“Adjusted free cash flow” for the first fiscal quarter of 2026 is defined as the amount of cash generated from operating activities ($(0.6) million) in excess of capital expenditures ($(3.1) million), net of proceeds, if any, from the sale of assets ($(0.0) million).

Management believes that these non-GAAP measures are useful to investors because each presents what management views as our core operating results for the relevant period. The adjustments to the applicable GAAP measures relate to occurrences or events that are outside of our core operations, and management believes that the use of these non-GAAP measures provides a consistent basis to evaluate our operating profitability and performance trends across comparable periods. These reconciling items are indicated on the accompanying reconciliation schedules and are more fully described in VPG’s consolidated financial statements presented in our Annual Report on Form 10-K and Quarterly Reports on Forms 10-Q.

Conference Call and Webcast:

A conference call will be held on Tuesday, May 12, 2026 at 9:00 a.m. ET (8:00 a.m. CT). To access the conference call, interested parties may call 1-888-596-4144 or internationally +1-646-968-2525 and use passcode 6155497, or log on to the investor relations page of the VPG website at ir.vpgsensors.com. A replay will be available approximately one hour after the completion of the call by calling toll-free 1-800-770-2030 or internationally +1-609-800-9909 and by using passcode 6155497. The replay will also be available on the “Events” page of investor relations section of the VPG website at ir.vpgsensors.com.

About VPG:

Vishay Precision Group, Inc. (VPG) is a leader in precision measurement and sensing technologies. Our sensors, weighing solutions and measurement systems optimize and enhance our customers’ product performance across a broad array of markets to make our world safer, smarter, and more productive. To learn more, visit VPG at www.vpgsensors.com and follow us on LinkedIn.

Forward-Looking Statements:

From time to time, information provided by us, including, but not limited to, statements in this press release, or other statements made by or on our behalf, may contain or constitute “forward-looking” information within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks, uncertainties, and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from those anticipated. Such statements are based on current expectations only, and are subject to certain risks, uncertainties, and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, expected, estimated, or projected. Among the factors that could cause actual results to materially differ include: general business and economic conditions; significant developments from the recent and potential changes in tariffs and trade regulation; impact of inflation; potential issues respecting the United States federal government debt ceiling; global labor and supply chain challenges; difficulties or delays in identifying, negotiating and completing acquisitions and integrating acquired companies; the inability to realize anticipated synergies and expansion possibilities; difficulties in new product development; changes in competition and technology in the markets that we serve and the mix of our products required to address these changes; changes in foreign currency exchange rates; political, economic, and health (including pandemics) instabilities; instability or disruption caused by military hostilities in the regions or countries in which we operate (including Israel); difficulties in implementing our cost reduction strategies, such as underutilization of production facilities, labor unrest or legal challenges to our lay-off or termination plans, operation of redundant facilities due to difficulties in transferring production to achieve efficiencies; compliance issues under applicable laws, such as export control laws, including the outcome of our voluntary self-disclosure of export control non-compliance; our ability to execute our corporate strategy and business continuity, operational and budget plans; and other factors affecting our operations, markets, products, services, and prices that are set forth in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025. We caution you not to place undue reliance on forward-looking statements, which speak only as of the date of this report or as of the dates otherwise indicated in such forward-looking statements. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Contact:

Steve Cantor
Vishay Precision Group, Inc.
781-222-3516
[email protected]

VISHAY PRECISION GROUP, INC.
Consolidated Condensed Statements of Operations
(Unaudited – In thousands, except per share amounts)

 
    Fiscal Quarter Ended  
    April 4, 2026     March 29, 2025  
Net revenues   $ 84,353     $ 71,741  
Costs of products sold     51,479       44,696  
Gross profit     32,874       27,045  
                 
Selling, general and administrative expenses     32,085       26,710  
Restructuring costs     449       395  
Operating income (loss)     340       (60 )
                 
Other expense:                
Interest expense     (329 )     (550 )
Other     (169 )     (677 )
Other expense     (498 )     (1,227 )
                 
Loss before taxes     (158 )     (1,287 )
                 
Income tax expense (benefit)     129       (332 )
                 
Net loss     (287 )     (955 )
Less: net earnings (loss) attributable to noncontrolling interests     32       (13 )
Net loss attributable to VPG stockholders   $ (319 )   $ (942 )
                 
Basic loss per share attributable to VPG stockholders   $ (0.02 )   $ (0.07 )
Diluted loss per share attributable to VPG stockholders   $ (0.02 )   $ (0.07 )
                 
Weighted average shares outstanding – basic     13,297       13,257  
Weighted average shares outstanding – diluted     13,297       13,257  

VISHAY PRECISION GROUP, INC.
Consolidated Condensed Balance Sheets
(In thousands)

 
    April 4, 2026     December 31, 2025  
    (Unaudited)          
Assets                
Current assets:                
Cash and cash equivalents   $ 82,486     $ 87,366  
Accounts receivable, net     61,415       56,348  
Inventories:                
Raw materials     32,124       32,760  
Work in process     28,355       25,794  
Finished goods     22,408       24,269  
Inventories, net     82,887       82,823  
                 
Prepaid expenses and other current assets     19,306       20,425  
Total current assets     246,094       246,962  
                 
Property and equipment:                
Land     2,364       2,382  
Buildings and improvements     79,267       78,737  
Machinery and equipment     139,543       137,230  
Software     12,082       11,692  
Construction in progress     3,268       4,162  
Accumulated depreciation     (160,843 )     (158,123 )
Property and equipment, net     75,681       76,080  
                 
Goodwill     47,237       47,367  
Intangible assets, net     37,186       38,227  
Operating lease right-of-use assets     22,653       22,892  
Other assets     24,989       24,361  
Total assets     453,840     $ 455,889  

VISHAY PRECISION GROUP, INC.
Consolidated Condensed Balance Sheets
(In thousands)

 
    April 4, 2026     December 31, 2025  
    (Unaudited)          
Liabilities and equity                
Current liabilities:                
Trade accounts payable   $ 11,712     $ 10,530  
Payroll and related expenses     18,900       19,569  
Other accrued expenses and other current liabilities     19,959       20,833  
Current portion of operating lease liabilities     4,439       4,347  
Total current liabilities     55,010       55,279  
                 
Long-term debt     20,612       20,583  
Deferred income taxes     4,267       3,834  
Operating lease liabilities     19,336       19,547  
Other liabilities     13,914       14,200  
Accrued pension and other postretirement costs     6,224       6,219  
Total liabilities     119,363       119,662  
                 
Equity:                
Common stock, par value $0.10 per share: 25,000,000 shares authorized; 12,278,113 shares outstanding as of April 4, 2026 and 12,256,197 shares outstanding as of December 31, 2025     1,342       1,340  
Class B convertible common stock, par value $0.10 per share: 3,000,000 shares authorized; 1,022,887 shares outstanding as of April 4, 2026 and December 31, 2025     103       103  
Treasury stock, at cost – 1,137,995 shares held at April 4, 2026 and December 31, 2025     (25,335 )     (25,335 )
Capital in excess of par value     204,829       204,360  
Retained earnings     196,951       197,270  
Accumulated other comprehensive loss     (43,173 )     (41,367 )
Total Vishay Precision Group, Inc. stockholders’ equity     334,717       336,371  
Noncontrolling interests     (240 )     (144 )
Total equity     334,477       336,227  
Total liabilities and equity   $ 453,840     $ 455,889  

  

VISHAY PRECISION GROUP, INC.
Consolidated Condensed Statements of Cash Flows
(Unaudited – In thousands)

 
    Three Fiscal Months Ended  
    April 4, 2026     March 29, 2025  
Operating activities                
Net loss   $ (287 )   $ (955 )
Adjustments to reconcile net earnings to net cash provided by operating activities:                
Depreciation and amortization     4,210       4,035  
Share-based compensation expense     837       545  
Inventory write-offs for obsolescence     606       800  
Deferred income tax expense     (487 )     (489 )
Foreign currency impacts and other items     (73 )     478  
Net changes in operating assets and liabilities:                
Accounts receivable     (5,508 )     1,823  
Inventories     (1,061 )     227  
Prepaid expenses and other current assets     958       (848 )
Trade accounts payable     1,333       253  
Other current liabilities     (599 )     292  
Other non current assets and liabilities, net     (463 )     (841 )
Accrued pension and other postretirement costs, net     (62 )     (71 )
Net cash (used in) provided by operating activities     (596 )     5,249  
                 
Investing activities                
Capital expenditures     (3,060 )     (1,507 )
Net cash used in investing activities     (3,060 )     (1,507 )
                 
Financing activities                
(Distributions) Contributions from noncontrolling interests     (127 )     147  
Payments of employee taxes on certain share-based arrangements     (375 )     (256 )
Net cash used in financing activities     (502 )     (109 )
Effect of exchange rate changes on cash and cash equivalents     (722 )     987  
(Decrease) Increase in cash and cash equivalents     (4,880 )     4,620  
Cash and cash equivalents at beginning of period     87,366       79,272  
Cash and cash equivalents at end of period   $ 82,486     $ 83,892  
                 
Supplemental disclosure of investing transactions:                
Capital expenditures accrued but not yet paid     796     $ 454  

  

VISHAY PRECISION GROUP, INC.
Reconciliation of Consolidated Adjusted Gross Profit, Operating Income, Net Earnings Attributable to VPG Stockholders and Diluted Earnings Per Share
(Unaudited – In thousands)






 
    Gross Profit     Operating Income     Net Earnings (loss) Attributable to VPG Stockholders     Diluted Earnings (loss) Per share  
Three months ended   April 4, 2026     March 29, 2025     April 4, 2026     March 29, 2025     April 4, 2026     March 29, 2025     April 4, 2026     March 29, 2025  
As reported – GAAP   $ 32,874     $ 27,045     $ 340     $ (60 )   $ (319 )   $ (942 )   $ (0.02 )   $ (0.07 )
As reported – GAAP Margins     39.0 %     37.7 %     0.4 %     (0.1 )%                     $  
Start-up costs           463             463             463           $ 0.04  
Restructuring costs (a)                 449       395       449       395       0.03     $ 0.03  
Share-based compensation cost (b)           9       837       545       837       545       0.06     $ 0.04  
Foreign currency exchange gain (c)                             243       972       0.02     $ 0.07  
Less: Tax effect of reconciling items and discrete tax items                             303       534       0.02     $ 0.04  
As Adjusted – Non GAAP   $ 32,874     $ 27,517     $ 1,626     $ 1,343     $ 907     $ 899     $ 0.07     $ 0.07  
As Adjusted – Non GAAP Margins    
39.0

%
    38.4 %    
1.9

%
    1.9 %                                

(a) Restructuring cost in 2026
(b) Share-based compensation cost excluded for Non-GAAP results, effective beginning 2026, with prior period comparability
(c) Impact of foreign currency exchange rates on assets and liabilities

VISHAY PRECISION GROUP, INC.
Reconciliation of Adjusted Gross Profit by segment
(Unaudited – In thousands)

 
    Fiscal Quarter Ended  
    April 4, 2026     March 29, 2025     December 31, 2025  
Sensors                        
Net revenues     33,314       27,056       30,402  
                         
As reported – GAAP     11,588       8,146       8,665  
As reported – GAAP Margins     34.8 %     30.1 %     28.5 %
Start-up costs           187        
As Adjusted – Non GAAP     11,588       8,333       8,665  
As Adjusted – Non GAAP Margins     34.8 %     30.8 %     28.5 %
                         
Weighing Solutions                        
Net revenues     30,236       26,438       27,739  
                         
As reported – GAAP     10,340       9,717       9,156  
As reported – GAAP Margins     34.2 %     36.8 %     33.0 %
Start-up costs           276        
As Adjusted – Non GAAP     10,340       9,993       9,156  
As Adjusted – Non GAAP Margins     34.2 %     37.8 %     33.0 %
                         
Measurement Systems                        
Net revenues     20,803       18,246       22,431  
                         
As reported – GAAP     10,946       9,182       11,844  
As reported – GAAP Margins     52.6 %     50.3 %     52.8 %
Acquisition purchase accounting adjustments                 110  
As Adjusted – Non GAAP     10,946       9,182       11,954  
As Adjusted – Non GAAP Margins     52.6 %     50.3 %     53.3 %

VISHAY PRECISION GROUP, INC.
Reconciliation of Adjusted EBITDA
(Unaudited – In thousands)

 
    Fiscal Quarter Ended  
    April 4, 2026     March 29, 2025     December 31, 2025  
Net loss attributable to VPG stockholders   $ (319 )   $ (942 )   $ (1,871 )
Interest Expense     329       550       412  
Income tax expense (benefit)     129       (332 )     1,235  
Depreciation     3,223       3,056       3,060  
Amortization     987       979       983  
Restructuring costs (a)     449       395       697  
Acquisition purchase accounting adjustments                 110  
Share-based compensation cost (b)     837       545       244  
Foreign currency exchange gain (c)     243       972       1,378  
ADJUSTED EBITDA   $ 5,878     $ 5,686     $ 6,248  
ADJUSTED EBITDA MARGIN     7.0 %     7.9 %     7.8 %

(a) Restructuring cost in 2026
(b) Share-based compensation cost excluded for Non-GAAP results, effective beginning 2026, with prior period comparability
(c) Impact of foreign currency exchange rates on assets and liabilities